Structure;SMILES;IUPAC Name;Name;MW;Plate Location;Plate number;Plate description;CAS;Catalog number;Concentration;Compound description;Solvent;Plate part number
;CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)\C=C\CCCCCCCCCCCCC;N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]hexadecanamide;C16 Ceramide;537,9;1-A02;1;ICCB Known Bioactives Library;24696-26-2;SL115;1mM;Bioactive lipids:  Activates PKC zeta;DMSO;2840
;CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO)NCCCCCCCC;(2S,3R,4E)-2-(octylamino)octadec-4-ene-1,3-diol;C8 Ceramine;411,7;1-A03;1;ICCB Known Bioactives Library;170926-06-4;SL145;1mM;Bioactive lipids:  Ceramide analog. Apoptosis inducer;DMSO;2840
;CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)N[C@H](C)CO;(5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]icosa-5,8,11,14-tetraenamide;(R)-(+)-Methandamide;361,6;1-A04;1;ICCB Known Bioactives Library;157182-49-5;FA021;1mM;CNS receptor ligands:  Cannabinoid CB1 receptor agonist;DMSO;2840
;[H][C@@]12CC[C@H]([C@H](C)CCCC(C)(C)O)[C@@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C;(1R,3S,5Z)-5-{2-[(1R,3aS,4E,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexane-1,3-diol;1α,25-Dihydroxyvitamin D3;416,6;1-A05;1;ICCB Known Bioactives Library;32222-06-3;DM200;1mM;Nuclear receptor ligands:  Vitamin D receptor agonist;DMSO;2840
;CCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCC;1-(decanoyloxy)-3-hydroxypropan-2-yl decanoate;1,2-Didecanoyl-glycerol (10:0);400,6;1-A06;1;ICCB Known Bioactives Library;82950-64-9;DG100;1mM;Bioactive lipids:  Activates PKC;DMSO;2840
;CCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCC;(2S)-1-hydroxy-3-(octanoyloxy)propan-2-yl octanoate;1,2-Dioctanoyl-SN-glycerol;344,5;1-A07;1;ICCB Known Bioactives Library;75685-80-2;DG112;1mM;Bioactive lipids:  Activates PKC;DMSO;2840
;CCCCCCCC\C=C/CCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCC\C=C/CCCCCCCC;1-hydroxy-3-[(9Z)-octadec-9-enoyloxy]propan-2-yl (9Z)-octadec-9-enoate;1,2-Dioleoyl-glycerol (18:1);621,0;1-A08;1;ICCB Known Bioactives Library;3738-74-7;DG115;1mM;Bioactive lipids:  Activates PKC;DMSO;2840
;CCCCC\C=C/CC1OC1C\C=C/C\C=C/CCCC(O)=O;(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoic acid;(±)11(12)-Epoxyeicosatrienoic acid;320,5;1-A09;1;ICCB Known Bioactives Library;123931-40-8;EE11;0.1mM;Bioactive lipids:  Bioactive arachidonic acid metabolite;DMSO;2840
;CCCCC\C=C/C[C@@H](O)\C=C\C=C/C\C=C/CCCC(O)=O;(5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid;12(R)-HETE;320,5;1-A10;1;ICCB Known Bioactives Library;82337-46-0;H112;0.1mM;Bioactive lipids:  Bioactive arachidonic acid metabolite;DMSO;2840
;CCCCC\C=C/C[C@H](O)\C=C\C=C/C\C=C/CCCC(O)=O;(5Z,8Z,10E,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid;12(S)-HETE;320,5;1-A11;1;ICCB Known Bioactives Library;54397-83-0;H012;0.1mM;Bioactive lipids:  Bioactive arachidonic acid metabolite;DMSO;2840
;CCCCC\C=C/C[C@H](OO)\C=C\C=C/C\C=C/CCCC(O)=O;(5Z,8Z,10E,12S,14Z)-12-hydroperoxyicosa-5,8,10,14-tetraenoic acid;12(S)-HPETE;336,5;1-B02;1;ICCB Known Bioactives Library;71774-10-2;HP012;0.1mM;Bioactive lipids:  Fatty acid hydroperoxide;DMSO;2840
;COCCCCCCCCCCCC(O)=O;12-methoxydodecanoic acid;12-Methoxydodecanoic acid;230,3;1-B03;1;ICCB Known Bioactives Library;92169-28-3;G234;1mM;Bioactive lipids:  Myristic acid analog;DMSO;2840
;CCCCC[C@H](O)\C=C\C=C/CCCCCCCC(O)=O;(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid;13(S)-HODE;296,4;1-B04;1;ICCB Known Bioactives Library;29623-28-7;HO013;0.1mM;Bioactive lipids:  Bioactive linoleic acid metabolite;DMSO;2840
;CCCCC[C@H](OO)\C=C\C=C/CCCCCCCC(O)=O;(9Z,11E,13S)-13-hydroperoxyoctadeca-9,11-dienoic acid;13(S)-HPODE;312,4;1-B05;1;ICCB Known Bioactives Library;33964-75-9;HP013;0.1mM;Bioactive lipids:  Fatty acid hydroperoxide;DMSO;2840
;CCCCC[C@H](O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O;7-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoctyl]-5-oxocyclopentyl]heptanoic acid;13,14-Dihydro-PGE1;356,5;1-B06;1;ICCB Known Bioactives Library;19313-28-1;PG048;1mM;Bioactive lipids:  Bioactive prostaglandin;DMSO;2840
;C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O;(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid;13-cis retinoic acid;300,4;1-B07;1;ICCB Known Bioactives Library;4759-48-2;GR102;1mM;Nuclear receptor ligands:  Retinoid receptor ligand;DMSO;2840
;CCCCCC(=O)\C=C\C=C/CCCCCCCC(O)=O;(9Z,11E)-13-oxooctadeca-9,11-dienoic acid;13-Keto-octadeca-9Z,11E-dienoic acid;294,4;1-B08;1;ICCB Known Bioactives Library;54739-30-9;KO013;0.1mM;Bioactive lipids:  Bioactive linoleic acid metabolite;DMSO;2840
;CCCCCC1OC1C\C=C/C\C=C/C\C=C/CCCC(O)=O;(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid;(±)14,15-Epoxyeicosa-5Z,8Z,11Z-trienoic acid;320,5;1-B09;1;ICCB Known Bioactives Library;81276-03-1;EE14;0.1mM;Bioactive lipids:  Bioactive arachidonic acid metabolite;DMSO;2840
;CCCCC[C@H](O)\C=C\C=C/C\C=C/C\C=C/CCCC(O)=O;(5Z,8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoic acid;15(S)-HETE;320,5;1-B10;1;ICCB Known Bioactives Library;54845-95-3;H015;0.1mM;Bioactive lipids:  Bioactive arachidonic acid metabolite;DMSO;2840
;CCCCC[C@H](OO)\C=C\C=C/C\C=C/C\C=C/CCCC(O)=O;(5Z,8Z,11Z,13E,15S)-15-hydroperoxyicosa-5,8,11,13-tetraenoic acid;15(S)-HPETE;336,5;1-B11;1;ICCB Known Bioactives Library;70981-96-3;HP015;0.1mM;Bioactive lipids:  Fatty acid hydroperoxide;DMSO;2840
;CCCCC\C=C\C=C1/[C@@H](C\C=C/CCCC(O)=O)C=CC1=O;(5Z)-7-[(1S,5E)-5-[(2E)-oct-2-en-1-ylidene]-4-oxocyclopent-2-en-1-yl]hept-5-enoic acid;15-deoxy-Prostaglandin J2;316,4;1-C02;1;ICCB Known Bioactives Library;87893-55-8;PG050;1mM;Bioactive lipids:  Bioactive prostaglandin;DMSO;2840
;CCCCCC(=O)\C=C\C=C/C\C=C/C\C=C/CCCC(O)=O;(5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid;15-Ketoicosatetraenoic acid;318,5;1-C03;1;ICCB Known Bioactives Library;81416-72-0;K015;0.1mM;Bioactive lipids:  Bioactive arachidonic acid metabolite;DMSO;2840
;CCCCC(C)(C)[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O;(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3R)-3-hydroxy-4,4-dimethyloct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid;16,16-Dimethyl-prostaglandin E2;380,5;1-C04;1;ICCB Known Bioactives Library;39746-25-3;PG021;1mM;Bioactive lipids:  Prostaglandin EP receptor agonist;DMSO;2840
;[H]C#CCCCCCCCCCCCCCCCC(O)=O;octadec-17-ynoic acid;17-Octadecynoic acid;280,4;1-C05;1;ICCB Known Bioactives Library;34450-18-5;EI103;1mM;Lipid biosynthesis:  Inhibits fatty acid omega oxidation;DMSO;2840
;O[C@@H](CCC1=CC=CC=C1)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O;(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid;17-Phenyl-trinor-prostaglandin E2;386,5;1-C06;1;ICCB Known Bioactives Library;38315-43-4;PG042;1mM;Bioactive lipids:  Prostaglandin EP1 receptor agonist;DMSO;2840
;CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(C)=O;(2-{[(2R)-2-(acetyloxy)-3-(hexadecanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium;1-Acyl-PAF;537,7;1-C07;1;ICCB Known Bioactives Library;84062-61-3;L134;1mM;Bioactive lipids:  PAF agonist;DMSO;2840
;CCCCCCCCCCCCCCCCOC[C@H](CO)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC;(2S)-1-(hexadecyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate;1-Hexadecyl-2-arachidonoyl-glycerol;603,0;1-C08;1;ICCB Known Bioactives Library;126721-87-7;DG140;1mM;Bioactive lipids:  DAG analog;DMSO;2840
;CCCCCCCCCCCCCCCCOCC(COP([O-])(=O)OCC[N+](C)(C)C)OC;3-(hexadecyloxy)-2-methoxypropyl 2-(trimethylazaniumyl)ethyl phosphate;1-Hexadecyl-2-methylglycero-3 PC;495,7;1-C09;1;ICCB Known Bioactives Library;78858-44-3;L106;1mM;Bioactive lipids:  PAF receptor agonist;DMSO;2840
;CCCCCCCCCCCCCCCCOCC(CO)OC(C)=O;1-(hexadecyloxy)-3-hydroxypropan-2-yl acetate;1-Hexadecyl-2-O-acetyl-glycerol;358,6;1-C10;1;ICCB Known Bioactives Library;77133-35-8;EI150;1mM;Bioactive lipids:  Blocks DAG activation of PKC;DMSO;2840
;CCCCCCCCCCCCCCCCOCC(CO)OC;3-(hexadecyloxy)-2-methoxypropan-1-ol;1-Hexadecyl-2-O-methyl-glycerol;330,5;1-C11;1;ICCB Known Bioactives Library;84337-41-7;EI149;1mM;Bioactive lipids:  Blocks DAG activation of PKC;DMSO;2840
;CCCCCCCCCCCCCCCCCCOC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC;(2R)-2-methoxy-3-(octadecyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate;1-Octadecyl-2-methylglycero-3 PC;523,7;1-D02;1;ICCB Known Bioactives Library;77286-66-9;L108;1mM;Bioactive lipids:  Inhibits PI-specific PLC;DMSO;2840
;CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](CO)OC(C)=O;(2S)-2-(acetyloxy)-3-hydroxypropyl (9Z)-octadec-9-enoate;1-Oleoyl 2-acetyl-glycerol;398,6;1-D03;1;ICCB Known Bioactives Library;86390-77-4;DG125;1mM;Bioactive lipids:  PKC activator;DMSO;2840
;CCCCCCCCCCCCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC;(2S)-1-hydroxy-3-(octadecanoyloxy)propan-2-yl (9Z,12Z)-octadeca-9,12-dienoate;1-Stearoyl-2-lineoyl-glycerol;621,0;1-D04;1;ICCB Known Bioactives Library;34487-26-8;DG135;1mM;Bioactive lipids:  PKC activator;DMSO;2840
;CCCCCCCCCCCCCCCCCC(=O)OC[C@H](CO)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC;(2S)-1-hydroxy-3-(octadecanoyloxy)propan-2-yl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate;1-stearoyl-2-arachidonyl-glycerol;645,0;1-D05;1;ICCB Known Bioactives Library;65914-84-3;DG130;1mM;Bioactive lipids:  PKC activator;DMSO;2840
;[H][C@@]12CC[C@H]([C@H](C)CC[C@@H](O)C(C)(C)O)[C@@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C;(3R,6R)-6-[(1R,3aS,4E,7aR)-4-{2-[(1Z,5S)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene}-7a-methyl-octahydro-1H-inden-1-yl]-2-methylheptane-2,3-diol;24,25-Dihydroxyvitamin D3;416,6;1-D06;1;ICCB Known Bioactives Library;40013-87-4;DM300;1mM;Nuclear receptor ligands:  Vitamin D receptor ligand;DMSO;2840
;[H][C@@]12CC[C@H]([C@H](C)CCCC(C)(C)O)[C@@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C;(1S,3Z)-3-{2-[(1R,3aS,4E,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexan-1-ol;25-Dihydroxyvitamin D3;400,6;1-D07;1;ICCB Known Bioactives Library;19356-17-3;DM100;1mM;Nuclear receptor ligands:  Vitamin D receptor ligand;DMSO;2840
;CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)OC(CO)CO;1,3-dihydroxypropan-2-yl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate;2-Arachidonoylglycerol;378,5;1-D08;1;ICCB Known Bioactives Library;53847-30-6;FA028;1mM;Endocannabinoids:  Cannabinoid CB1 receptor agonist;DMSO;2840
;CCCCCCCCCCCCCCC(F)C(O)=O;2-fluorohexadecanoic acid;2-Fluoropalmitic acid;274,4;1-D09;1;ICCB Known Bioactives Library;89270-22-4;G231;1mM;Bioactive lipids:  Protein palmitoylation inhibitor;DMSO;2840
;CCCCCCCCCCCCC(O)C(O)=O;2-hydroxytetradecanoic acid;2-Hydroxymyristic acid;244,4;1-D10;1;ICCB Known Bioactives Library;2507-55-3;G230;1mM;Bioactive lipids:  Protein myristoylation inhibitor;DMSO;2840
;C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(=O)NC1=CC=C(O)C=C1;(2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenamide;4-hydroxyphenylretinamide;391,5;1-D11;1;ICCB Known Bioactives Library;6546-68-6;GR103;1mM;Nuclear receptor ligands:  Retinoid receptor agonist / apoptosis inducer;DMSO;2840
;CCCCCCCCCCOCCC(O)=O;3-(decyloxy)propanoic acid;4-Oxatetradecanoic acid;230,3;1-E02;1;ICCB Known Bioactives Library;7420-16-8;G232;1mM;Bioactive lipids:  Myristic acid analog;DMSO;2840
;CCCCC\C=C/C\C=C/C\C=C/C=C/[C@@H](O)CCCC(O)=O;(5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid;5(S)-HETE;320,5;1-E03;1;ICCB Known Bioactives Library;70608-72-9;H005;0.1mM;Bioactive lipids:  Bioactive arachidonic acid metabolite;DMSO;2840
;;;Blank;;1-E04;1;ICCB Known Bioactives Library;;;;;;2840
;CCCCC\C=C/C\C=C/C\C=C/CC1OC1CCCC(O)=O;4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoic acid;5,6-Epoxyeicosatrienoic acid;320,5;1-E05;1;ICCB Known Bioactives Library;184488-43-5;EE56;0.1mM;Bioactive lipids:  Bioactive arachidonic acid metabolite;DMSO;2840
;CCCCCC#CCC#CCC#CCC#CCCCC(O)=O;icosa-5,8,11,14-tetraynoic acid;5,8,11,14-Eicosatetraynoic acid;296,4;1-E06;1;ICCB Known Bioactives Library;1191-85-1;ET004;1mM;Bioactive lipids:  Cyclooxygenase & lipoxygenase inhibitor;DMSO;2840
;CCCCCCCCC#CCC#CCC#CCCCC(O)=O;icosa-5,8,11-triynoic acid;5,8,11-Eicosatriynoic acid;300,4;1-E07;1;ICCB Known Bioactives Library;13488-22-7;ET003;1mM;Bioactive lipids:  Lipoxygenase inhibitor;DMSO;2840
;CCCCC\C=C/C\C=C/C\C=C/C=C/C(=O)CCCC(O)=O;(6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid;5-Ketoeicosatetraenoic acid;318,5;1-E08;1;ICCB Known Bioactives Library;106154-18-1;K005;0.1mM;Bioactive lipids:  5-KETE receptor (R527) agonist;DMSO;2840
;[H]C(=O)C1=C2NC3=C(C=CC=C3)C2=CC2=C1C1=C(N2)C=CC=C1;5H,11H-indolo[3,2-b]carbazole-6-carbaldehyde;6-Formylindolo [3,2-B] carbazole;284,3;1-E09;1;ICCB Known Bioactives Library;172922-91-7;GR206;1mM;Bioactive lipids:  AHR agonist;DMSO;2840
;CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(=O)CCCCC(O)=O;7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-6-oxoheptanoic acid;6-Keto-prostaglandin F1a;370,5;1-E10;1;ICCB Known Bioactives Library;58962-34-8;PG017;1mM;Bioactive lipids:  Bioactive prostaglandin;DMSO;2840
;CCCCCCCCCCC\C=C/C(C)(C)\C=C/CCCC(O)=O;(5Z,8Z)-7,7-dimethylicosa-5,8-dienoic acid;7,7-Dimethyleicosadienoic acid;336,6;1-E11;1;ICCB Known Bioactives Library;89560-01-0;EI112;1mM;Bioactive lipids:  PLA2 inhibitor;DMSO;2840
;CCCCC\C=C/C\C=C/CC1OC1C\C=C/CCCC(O)=O;(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoic acid;8,9-Epoxyeicosatrienoic acid;320,5;1-F02;1;ICCB Known Bioactives Library;81246-85-7;EE89;0.1mM;Bioactive lipids:  Bioactive arachidonic acid metabolite;DMSO;2840
;CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@H]1C\C=C/CCCC(O)=O;(5Z)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoic acid;8-epi-Prostaglandin F2a;354,5;1-F03;1;ICCB Known Bioactives Library;27415-26-5;PG049;1mM;Bioactive lipids:  Thromboxane TP receptor agonist;DMSO;2840
;CCCCC\C=C/C=C/[C@H](O)CCCCCCCC(O)=O;(9R,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid;9(S)-HODE;296,4;1-F04;1;ICCB Known Bioactives Library;73543-67-6;HO409;0.1mM;Bioactive lipids:  Bioactive linoleic acid metabolite;DMSO;2840
;CCCCC\C=C/C=C/[C@H](CCCCCCCC(O)=O)OO;(9S,10E,12Z)-9-hydroperoxyoctadeca-10,12-dienoic acid;9(S)-HPODE;312,4;1-F05;1;ICCB Known Bioactives Library;29774-12-7;HP019;0.1mM;Bioactive lipids:  Fatty acid hydroperoxide;DMSO;2840
;CCCCCCCC\C=C/CCCCCCCC(N)=O;(9Z)-octadec-9-enamide;9,10-Octadecenoamide;281,5;1-F06;1;ICCB Known Bioactives Library;301-02-0;FA025;1mM;Endocannabinoids:  Endogenous sleep inducing lipid;DMSO;2840
;CCCCC[C@H](O)\C=C\[C@H]1[C@@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O;(5Z)-7-[(1R,2R,3S,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoic acid;9a,11b-Prostaglandin F2;354,5;1-F07;1;ICCB Known Bioactives Library;38432-87-0;PG031;1mM;Bioactive lipids:  Bioactive prostaglandin;DMSO;2840
;CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H](O)[C@@H]1C\C=C/CCCC(O)=O;(5Z)-7-[(1R,2R,3R,5R)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoic acid;9b,11a-Prostaglandin F2;354,5;1-F08;1;ICCB Known Bioactives Library;4510-16-1;PG030;1mM;Bioactive lipids:  Bioactive prostaglandin;DMSO;2840
;C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O;(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid;9-cis Retinoic acid;300,4;1-F09;1;ICCB Known Bioactives Library;5300-03-8;GR101;1mM;Nuclear receptor ligands:  Retinoid RXR agonist;DMSO;2840
;COC(=O)CNC(=O)C(=O)OC;methyl 2-(2-methoxy-2-oxoacetamido)acetate;Dimethyloxaloylglycine;175,1;1-F10;1;ICCB Known Bioactives Library;89464-63-1;EI347;1mM;Inhibitor:  Prolyl-4-hydroxylase inhibitor;DMSO;2840
;CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O;(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoic acid;Adrenic acid (22:4, n-6);332,5;1-F11;1;ICCB Known Bioactives Library;28874-58-0;FA011;1mM;Bioactive lipids:  Polyunsaturated fatty acid;DMSO;2840
;CC(C)=CCC\C(C)=C\CSC[C@H](NC(C)=O)C(O)=O;(2R)-3-{[(2E)-3,7-dimethylocta-2,6-dien-1-yl]sulfanyl}-2-acetamidopropanoic acid;N-Acetyl-S-geranyl-L-cysteine;299,4;1-G02;1;ICCB Known Bioactives Library;135784-50-8;G221;1mM;Bioactive lipids:  Negative control for AGGC and AFC;DMSO;2840
;CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CSC[C@H](NC(C)=O)C(O)=O;(2R)-2-acetamido-3-{[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]sulfanyl}propanoic acid;N-acetyl-S-geranylgeranyl-L-Cysteine;435,7;1-G03;1;ICCB Known Bioactives Library;139332-94-8;G220;1mM;Bioactive lipids:  ICMT inhibitor;DMSO;2840
;CC1=C(N(N=C1C(=O)NN1CCCCC1)C1=CC=C(Cl)C=C1Cl)C1=CC=C(I)C=C1;1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide;AM-251;555,2;1-G04;1;ICCB Known Bioactives Library;18323-66-8;CR108;1mM;CNS receptor ligands:  Cannabinoid CB1 receptor antagonist;DMSO;2840
;CC1(C)CCC(C)(C)C2=C1C=CC(=C2)C(=O)NC1=CC=C(C=C1)C(O)=O;4-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalene-2-amido)benzoic acid;AM-580;351,4;1-G05;1;ICCB Known Bioactives Library;102121-60-8;GR104;1mM;Nuclear receptor ligands:  Retinoid RAR agonist;DMSO;2840
;CCCCC\C=C/C\C=C/CCCCCCCC(=O)NCCO;(9Z,12Z)-N-(2-hydroxyethyl)octadeca-9,12-dienamide;Anandamide (18:2,n-6);323,5;1-G06;1;ICCB Known Bioactives Library;68171-52-8;FA026;1mM;Endocannabinoids:  Cannabinoid receptor agonist;DMSO;2840
;CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(=O)NCCO;(8Z,11Z,14Z)-N-(2-hydroxyethyl)icosa-8,11,14-trienamide;Anandamide (20:3,n-6);349,6;1-G07;1;ICCB Known Bioactives Library;150314-34-4;FA019;1mM;Endocannabinoids:  Cannabinoid receptor agonist;DMSO;2840
;CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCO;(5Z,8Z,11Z,14Z)-N-(2-hydroxyethyl)icosa-5,8,11,14-tetraenamide;Anandamide (20:4, n-6);347,5;1-G08;1;ICCB Known Bioactives Library;94421-68-8;FA017;1mM;Endocannabinoids:  Cannabinoid receptor agonist;DMSO;2840
;CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(=O)NCCO;(7Z,10Z,13Z,16Z)-N-(2-hydroxyethyl)docosa-7,10,13,16-tetraenamide;Anandamide (22:4,n-6);375,6;1-G09;1;ICCB Known Bioactives Library;150314-35-5;FA020;1mM;Endocannabinoids:  Cannabinoid receptor agonist;DMSO;2840
;CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(N)=O;(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenamide;Arachidonamide;303,5;1-G10;1;ICCB Known Bioactives Library;85146-53-8;FA022;1mM;Endocannabinoids:  Bioactive arachidonic acid metabolite;DMSO;2840
;CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O;(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid;Arachidonic acid (20:4, n-6);304,5;1-G11;1;ICCB Known Bioactives Library;506-32-1;FA003;1mM;Bioactive lipids:  Polyunsaturated fatty acid;DMSO;2840
;CCCCCCCCCCCCCCCCOC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC;(2-{[(2R)-3-(hexadecyloxy)-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium;Arachidonoyl-PAF;768,1;1-H02;1;ICCB Known Bioactives Library;86288-11-1;L102;1mM;Bioactive lipids:  PAF precursor;DMSO;2840
;COC1=CC=C2N(C(=O)C3=CC=C(Cl)C=C3)C(C)=C(CC(=O)N3CCOCC3)C2=C1;2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-(morpholin-4-yl)ethan-1-one;BML-190;426,9;1-H03;1;ICCB Known Bioactives Library;2854-32-2;CR104;1mM;Bioactive lipids:  Cannabinoid CB1 inverse agonist;DMSO;2840
;CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO)NC(C)=O;N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]acetamide;C2 Ceramide;341,5;1-H04;1;ICCB Known Bioactives Library;3102-57-6;SL100;1mM;Bioactive lipids:  Apoptosis inducer;DMSO;2840
;CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O;N-[(2S,3R)-1,3-dihydroxyoctadecan-2-yl]acetamide;C2 Dihydroceramide;343,5;1-H05;1;ICCB Known Bioactives Library;13031-64-6;SL101;1mM;Bioactive lipids:  Negative control for C2 ceramide;DMSO;2840
;CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO)NC(=O)CCCCCCC;N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]octanamide;C8 Ceramide;425,7;1-H06;1;ICCB Known Bioactives Library;74713-59-0;SL112;1mM;Bioactive lipids:  Stimulates Cer-activated PK;DMSO;2840
;CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(=O)CCCCCCC;N-[(2S,3R)-1,3-dihydroxyoctadecan-2-yl]octanamide;C8 Dihydroceramide;427,7;1-H07;1;ICCB Known Bioactives Library;145774-33-0;SL113;1mM;Bioactive lipids:  Negative control for C8 ceramide;DMSO;2840
;CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H]2C\C(C[C@H]12)=C/CCCC(O)=O;5-[(2E,3aS,4R,5R,6aS)-5-hydroxy-4-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-octahydropentalen-2-ylidene]pentanoic acid;Carbacyclin;350,5;1-H08;1;ICCB Known Bioactives Library;69552-46-1;PG035;1mM;Bioactive lipids:  PPAR delta agonist;DMSO;2840
;CC1(COC2=CC=C(CC3SC(=O)NC3=O)C=C2)CCCCC1;5-({4-[(1-methylcyclohexyl)methoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione;Ciglitazone;333,4;1-H09;1;ICCB Known Bioactives Library;74772-77-3;GR205;1mM;Nuclear receptor ligands:  PPAR gamma agonist;DMSO;2840
;CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1;ethyl 2-(4-chlorophenoxy)-2-methylpropanoate;Clofibrate;242,7;1-H10;1;ICCB Known Bioactives Library;637-07-0;EI160;1mM;Nuclear receptor ligands:  PPAR alpha agonist;DMSO;2840
;O[C@@H](COC1=CC=CC(Cl)=C1)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O;(5Z)-7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-1-yl]-3,5-dihydroxycyclopentyl]hept-5-enoic acid;Cloprostenol;424,9;1-H11;1;ICCB Known Bioactives Library;55028-72-3;RA106;1mM;Bioactive lipids:  Prostaglandin FP receptor agonist;DMSO;2840
;CCCCCCCCCCCCCCCCOC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)NC;(2-{[(2R)-3-(hexadecyloxy)-2-[(methylcarbamoyl)oxy]propyl phosphonato]oxy}ethyl)trimethylazanium;C-PAF;538,7;2-A02;2;ICCB Known Bioactives Library;91575-58-5;L120;1mM;Bioactive lipids:  PAF receptor agonist;DMSO;2840
;;;Blank;;2-A03;2;ICCB Known Bioactives Library;;;;;;2840
;CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O;(8Z,11Z,14Z)-icosa-8,11,14-trienoic acid;Dihomo-gamma-linolenic acid;306,5;2-A04;2;ICCB Known Bioactives Library;1783-84-2;FA009;1mM;Bioactive lipids:  Polyunsaturated fatty acid ;DMSO;2840
;CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CO;(2S,3R)-2-aminooctadecane-1,3-diol;Dihydrosphingosine;301,5;2-A05;2;ICCB Known Bioactives Library;3102-56-5;SL125;1mM;Bioactive lipids:  Apoptosis inducer;DMSO;2840
;C(C1=CNC2=C1C=CC=C2)C1=CNC2=C1C=CC=C2;3-(1H-indol-3-ylmethyl)-1H-indole;Diidolylmethane;246,3;2-A06;2;ICCB Known Bioactives Library;1968-05-4;GR207;1mM;Nuclear receptor ligands:  AHR agonist;DMSO;2840
;CCCCCCCCCCCCCCC[C@H](O)[C@@H](N)CO;(2S,3S)-2-aminooctadecane-1,3-diol;DL-Dihydrosphingosine;301,5;2-A07;2;ICCB Known Bioactives Library;73938-69-9;SL205;1mM;Lipid biosynthesis:  Sphingosine kinase inhibitor;DMSO;2840
;CCCCCCCCCC(=O)N[C@H](CN1CCOCC1)[C@H](O)C1=CC=CC=C1;N-[(1R,2R)-1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]decanamide;DL-PDMP;390,6;2-A08;2;ICCB Known Bioactives Library;73257-80-4;SL210;1mM;Lipid biosynthesis:  Glucosylceramide synthase inhibitor;DMSO;2840
;CCCCCCCCCCCCCCCC(=O)N[C@H](CN1CCOCC1)[C@H](O)C1=CC=CC=C1;N-[(1R,2R)-1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide;DL-PPMP;474,7;2-A09;2;ICCB Known Bioactives Library;149022-18-4;SL215;1mM;Lipid biosynthesis:  Glucosylceramide synthase inhibitor;DMSO;2840
;CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O;(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid;Docosahexaenoic acid(22:6 n-3);328,5;2-A10;2;ICCB Known Bioactives Library;6217-54-5;FA002;1mM;Bioactive lipids:  Polyunsaturated fatty acid ;DMSO;2840
;CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O;(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoic acid;Docosapentaenoic acid;330,5;2-A11;2;ICCB Known Bioactives Library;2234-74-4;FA012;1mM;Bioactive lipids:  Polyunsaturated fatty acid ;DMSO;2840
;CC\C=C/C\C=C/C\C=C/CCCCCCCCCCCC(O)=O;(13Z,16Z,19Z)-docosa-13,16,19-trienoic acid;Docosatrienoic acid (22:3 n-3);334,5;2-B02;2;ICCB Known Bioactives Library;28845-86-5;FA010;1mM;Bioactive lipids:  Polyunsaturated fatty acid ;DMSO;2840
;CCCCCCCCCCC\C=C/C\C=C/CCCC(O)=O;(5Z,8Z)-icosa-5,8-dienoic acid;Eicosa-5,8-dienoic acid (20:2 n-12);308,5;2-B03;2;ICCB Known Bioactives Library;25535-07-1;FA024;1mM;Bioactive lipids:  Polyunsaturated fatty acid ;DMSO;2840
;CCCCC\C=C/C\C=C/CCCCCCCCCC(O)=O;(11Z,14Z)-icosa-11,14-dienoic acid;Eicosadienoic acid (20:2 n-6);308,5;2-B04;2;ICCB Known Bioactives Library;2091-39-6;FA007;1mM;Bioactive lipids:  Polyunsaturated fatty acid ;DMSO;2840
;CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O;(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid;Eicosapentaenoic acid (20:5 n-3);302,5;2-B05;2;ICCB Known Bioactives Library;10417-94-4;FA001;1mM;Bioactive lipids:  Polyunsaturated fatty acid ;DMSO;2840
;CC\C=C/C\C=C/C\C=C/CCCCCCCCCC(O)=O;(11Z,14Z,17Z)-icosa-11,14,17-trienoic acid;Eicosatrienoic acid (20:3 n-3);306,5;2-B06;2;ICCB Known Bioactives Library;2091-27-2;FA008;1mM;Bioactive lipids:  Polyunsaturated fatty acid ;DMSO;2840
;CCCCCCCCCCCCCCCCOC[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(C)=O;(2-{[(2S)-2-(acetyloxy)-3-(hexadecyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium;Enantio-PAF C16;523,7;2-B07;2;ICCB Known Bioactives Library;117985-57-6;L110;1mM;Bioactive lipids:  Negative control for PAF;DMSO;2840
;CC(C)=CCC\C(C)=C\CC\C(C)=C\CSCC(O)=O;2-{[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]sulfanyl}acetic acid;Farnesylthioacetic acid;296,5;2-B08;2;ICCB Known Bioactives Library;135784-48-4;G222;1mM;Bioactive lipids:  Carboxymethylation inhibitor;DMSO;2840
;O[C@@H](COC1=CC=CC(=C1)C(F)(F)F)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O;(5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-en-1-yl]cyclopentyl]hept-5-enoic acid;Fluprostenol;458,5;2-B09;2;ICCB Known Bioactives Library;40666-16-8;RA105;1mM;Bioactive lipids:  Prostaglandin FP receptor agonist;DMSO;2840
;CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O;(6Z,9Z,12Z)-octadeca-6,9,12-trienoic acid;Gamma-linolenic acid (18:3 n-6);278,4;2-B10;2;ICCB Known Bioactives Library;506-26-3;FA006;1mM;Bioactive lipids:  Polyunsaturated fatty acid ;DMSO;2840
;CCCCC\C=C/CC1OC1CCCCCCCC(O)=O;8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoic acid;Leukotoxin A (9,10-EODE);296,4;2-B11;2;ICCB Known Bioactives Library;6814-52-4;LE009;0.1mM;Bioactive lipids:  Bioactive linoleic acid metabolite;DMSO;2840
;CCCCCC1OC1C\C=C/CCCCCCCC(O)=O;(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoic acid;Leukotoxin B (12,13-EODE);296,4;2-C02;2;ICCB Known Bioactives Library;948310-68-7;LE012;0.1mM;Bioactive lipids:  Bioactive linoleic acid metabolite;DMSO;2840
;CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O;(5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid;Leukotriene B4;336,5;2-C03;2;ICCB Known Bioactives Library;71160-24-2;LB004;0.1mM;Bioactive lipids:  Leukotriene B4 receptor agonist;DMSO;2840
;CCCCC\C=C/C\C=C/C=C/C=C/[C@@H](SC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O)[C@@H](O)CCCC(O)=O;(5S,6R,7E,9E,11Z,14Z)-6-{[(2R)-2-[(4S)-4-amino-4-carboxybutanamido]-2-[(carboxymethyl)carbamoyl]ethyl]sulfanyl}-5-hydroxyicosa-7,9,11,14-tetraenoic acid;Leukotriene C4;625,8;2-C04;2;ICCB Known Bioactives Library;72025-60-6;LC004;0.1mM;Bioactive lipids:  CysLT receptor agonist;DMSO;2840
;CCCCC\C=C/C\C=C/C=C/C=C/[C@@H](SC[C@H](N)C(=O)NCC(O)=O)[C@@H](O)CCCC(O)=O;(5S,6R,7E,9E,11Z,14Z)-6-{[(2R)-2-amino-2-[(carboxymethyl)carbamoyl]ethyl]sulfanyl}-5-hydroxyicosa-7,9,11,14-tetraenoic acid;Leukotriene D4;496,7;2-C05;2;ICCB Known Bioactives Library;73836-78-9;LD004;0.1mM;Bioactive lipids:  CysLT receptor agonist;DMSO;2840
;CCCCC\C=C/C\C=C/C=C/C=C/[C@@H](SC[C@H](N)C(O)=O)[C@@H](O)CCCC(O)=O;(5S,6R,7E,9E,11Z,14Z)-6-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-5-hydroxyicosa-7,9,11,14-tetraenoic acid;Leukotriene E4;439,6;2-C06;2;ICCB Known Bioactives Library;75715-89-8;LE004;0.1mM;Bioactive lipids:  CysLT1 receptor agonist;DMSO;2840
;CCCCC\C=C/C\C=C/CCCCCCCC(N)=O;(9Z,12Z)-octadeca-9,12-dienamide;Linoleamide;279,5;2-C07;2;ICCB Known Bioactives Library;3072-13-7;FA023;1mM;Endocannabinoids:  Bioactive linoleic acid metabolite;DMSO;2840
;CCCCC\C=C/C\C=C/CCCCCCCC(O)=O;(9Z,12Z)-octadeca-9,12-dienoic acid;Linoleic acid;280,4;2-C08;2;ICCB Known Bioactives Library;60-33-3;FA014;1mM;Bioactive lipids:  Polyunsaturated fatty acid ;DMSO;2840
;CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O;(9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid;Linolenic acid (18:3 n-3);278,4;2-C09;2;ICCB Known Bioactives Library;463-40-1;FA005;1mM;Bioactive lipids:  Polyunsaturated fatty acid ;DMSO;2840
;;;Blank;;2-C10;2;ICCB Known Bioactives Library;;;;;;2840
;CCCCCCCCCCCCCCCC(=O)N[C@@H](COP(O)(O)=O)C(O)=O;(2S)-2-hexadecanamido-3-(phosphonooxy)propanoic acid;L-NASPA;423,5;2-C11;2;ICCB Known Bioactives Library;155915-46-1;LP101;1mM;Bioactive lipids:  LPA agonist / antagonist;DMSO;2840
;CCCC1=C(OCCCCC2=NN=NN2)C=CC(C(C)=O)=C1O;1-{2-hydroxy-3-propyl-4-[4-(1H-1,2,3,4-tetrazol-5-yl)butoxy]phenyl}ethan-1-one;LY-171883;318,4;2-D02;2;ICCB Known Bioactives Library;88107-10-2;RA101;1mM;Bioactive lipids:  Leukotriene D4 receptor antagonist;DMSO;2840
;CCCCCCCCCCCCCCCCOC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C;(2-{[(2R)-3-(hexadecyloxy)-2-hydroxypropyl phosphonato]oxy}ethyl)trimethylazanium;Lyso-PAF C16;481,6;2-D03;2;ICCB Known Bioactives Library;52691-62-0;L101;1mM;Bioactive lipids:  Inactive PAF metabolite;DMSO;2840
;[Na+].CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)COP(O)([O-])=O;sodium (2R)-3-(hydrogen phosphonatooxy)-2-hydroxypropyl (9Z)-octadec-9-enoate;Lysophosphatidic acid·Na;458,5;2-D04;2;ICCB Known Bioactives Library;325465-93-9;LP100;1mM;Bioactive lipids:  LPA receptor antagonist;DMSO;2840
;CCCCCCCCCCCCCC(=O)N[C@H](C)[C@@H](O)C1=CC=CC=C1;N-[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]tetradecanamide;D-erythro-MAPP;361,6;2-D05;2;ICCB Known Bioactives Library;66085-59-4;SL221;1mM;Lipid biosynthesis:  Ceramidase inhibitor;DMSO;2840
;CCCCCCCCCCCCCC(=O)N[C@@H](C)[C@H](O)C1=CC=CC=C1;N-[(1R,2S)-1-hydroxy-1-phenylpropan-2-yl]tetradecanamide;L-erythro-MAPP;361,6;2-D06;2;ICCB Known Bioactives Library;143492-38-0;SL222;1mM;Lipid biosynthesis:  Negative control for D-erythro-MAPP;DMSO;2840
;CCCCCCCC\C=C/C\C=C/C\C=C/CCCC(O)=O;(5Z,8Z,11Z)-icosa-5,8,11-trienoic acid;Mead acid (20:3 n-9);306,5;2-D07;2;ICCB Known Bioactives Library;20590-32-3;FA004;1mM;Bioactive lipids:  Polyunsaturated fatty acid ;DMSO;2840
;CCCCCCCC\C=C/C\C=C/C\C=C/CCCC(=O)NCCO;(5Z,8Z,11Z)-N-(2-hydroxyethyl)icosa-5,8,11-trienamide;Mead ethanolamide;349,6;2-D08;2;ICCB Known Bioactives Library;169232-04-6;FA027;1mM;Endocannabinoids:  Cannabinoid receptor agonist;DMSO;2840
;COC(C)(C)CCCC(C)C\C=C\C(\C)=C\C(O)=O;(2E,4E)-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoic acid;Methoprene acid;268,4;2-D09;2;ICCB Known Bioactives Library;53092-52-7;GR106;1mM;Nuclear receptor ligands:  Retinoid RXR agonist;DMSO;2840
;CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O;7-[(1R,2R,3R)-3-hydroxy-2-[(1E)-4-hydroxy-4-methyloct-1-en-1-yl]-5-oxocyclopentyl]heptanoic acid;Misoprostol, free acid;368,5;2-D10;2;ICCB Known Bioactives Library;59122-46-2;PG052;1mM;Bioactive lipids:  Prostaglandin EP receptor agonist;DMSO;2840
;CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO)N(C)C;(2S,3R,4E)-2-(dimethylamino)octadec-4-ene-1,3-diol;N,N-Dimethylsphingosine;327,5;2-D11;2;ICCB Known Bioactives Library;119567-63-4;SL105;1mM;Lipid biosynthesis:  Sphingosine kinase inhibitor;DMSO;2840
;CCCCC\C=C/C\C=C/C=C/C=C/[C@@H](SCC(NC(C)=O)C(O)=O)[C@@H](O)CCCC(O)=O;(5S,6R,7E,9E,11Z,14Z)-6-[(2-carboxy-2-acetamidoethyl)sulfanyl]-5-hydroxyicosa-7,9,11,14-tetraenoic acid;N-Acetyl-leukotriene E4;481,6;2-E02;2;ICCB Known Bioactives Library;80115-95-3;LEA004;0.1mM;Bioactive lipids:  Bioactive arachidonic acid metabolite;DMSO;2840
;CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCC(O)=O;2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenamido]acetic acid;N-arachidonoylglycine;361,5;2-E03;2;ICCB Known Bioactives Library;179113-91-8;FA029;1mM;Endocannabinoids:  FAAH inhibitor;DMSO;2840
;CCCCC\C=C/C\C=C/CCCCCCCC(=O)NCC(O)=O;2-[(9Z,12Z)-octadeca-9,12-dienamido]acetic acid;N-linoleoylglycine;337,5;2-E04;2;ICCB Known Bioactives Library;2764-03-6;FA030;1mM;Endocannabinoids:  FAAH inhibitor;DMSO;2840
;CCCCCCCCCCCCCCCCOC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(C)=O;(2-{[(2R)-2-(acetyloxy)-3-(hexadecyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium;PAF C16;523,7;2-E05;2;ICCB Known Bioactives Library;74389-68-7;L100;1mM;Bioactive lipids:  PAF receptor agonist;DMSO;2840
;CCCCCCCCCCCCCCCCCCOC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(C)=O;(2-{[(2R)-2-(acetyloxy)-3-(octadecyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium;PAF C18;551,7;2-E06;2;ICCB Known Bioactives Library;79549-26-1;L105;1mM;Bioactive lipids:  PAF receptor agonist;DMSO;2840
;CCCCCCCC\C=C/CCCCCCCCOC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(C)=O;(2-{[(2R)-2-(acetyloxy)-3-[(9Z)-octadec-9-en-1-yloxy]propyl phosphonato]oxy}ethyl)trimethylazanium;PAF C18:1;549,7;2-E07;2;ICCB Known Bioactives Library;86288-90-1;L107;1mM;Bioactive lipids:  PAF receptor agonist;DMSO;2840
;CCCCCCCCCCCCCCCC(=O)NCCO;N-(2-hydroxyethyl)hexadecanamide;Palmitylethanolamide;299,5;2-E08;2;ICCB Known Bioactives Library;544-31-0;FA018;1mM;Endocannabinoids:  Cannabinoid CB2 receptor agonist;DMSO;2840
;CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC;[2,3-bis(hexadecanoyloxy)propoxy]phosphonic acid;Dipalmitoylphosphatidic acid;648,9;2-E09;2;ICCB Known Bioactives Library;71065-87-7;LP103;1mM;Bioactive lipids:  Activates MAP kinase cascade;DMSO;2840
;CCCCC[C@H](O)\C=C\[C@H]1C=CC(=O)[C@@H]1CCCCCCC(O)=O;7-[(1R,2S)-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopent-3-en-1-yl]heptanoic acid;Prostaglandin A1;336,5;2-E10;2;ICCB Known Bioactives Library;14152-28-4;PG001;1mM;Bioactive lipids:  Bioactive prostaglandin;DMSO;2840
;CCCCC[C@H](O)\C=C\[C@H]1C=CC(=O)[C@@H]1C\C=C/CCCC(O)=O;(5Z)-7-[(1R,2S)-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopent-3-en-1-yl]hept-5-enoic acid;Prostaglandin A2;334,4;2-E11;2;ICCB Known Bioactives Library;13345-50-1;PG002;1mM;Bioactive lipids:  Bioactive prostaglandin;DMSO;2840
;CCCCC[C@H](O)\C=C\C1=C(CCCCCCC(O)=O)C(=O)CC1;7-{2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopent-1-en-1-yl}heptanoic acid;Prostaglandin B1;336,5;2-F02;2;ICCB Known Bioactives Library;13345-51-2;PG003;1mM;Bioactive lipids:  Bioactive prostaglandin;DMSO;2840
;CCCCC[C@H](O)\C=C\C1=C(C\C=C/CCCC(O)=O)C(=O)CC1;(5Z)-7-{2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopent-1-en-1-yl}hept-5-enoic acid;Prostaglandin B2;334,4;2-F03;2;ICCB Known Bioactives Library;13367-85-6;PG004;1mM;Bioactive lipids:  Bioactive prostaglandin;DMSO;2840
;CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](C\C=C/CCCC(O)=O)[C@@H](O)CC1=O;(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoic acid;Prostaglandin  D2;352,5;2-F04;2;ICCB Known Bioactives Library;41598-07-6;PG005;1mM;Bioactive lipids:  Prostaglandin DP receptor agonist;DMSO;2840
;CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O;7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoic acid;Prostaglandin  E1;354,5;2-F05;2;ICCB Known Bioactives Library;745-65-3;PG006;1mM;Bioactive lipids:  Prostaglandin EP receptor agonist;DMSO;2840
;CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O;(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid;Prostaglandin  E2;352,5;2-F06;2;ICCB Known Bioactives Library;363-24-6;PG007;1mM;Bioactive lipids:  Prostaglandin EP receptor agonist;DMSO;2840
;CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(O)=O;7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]heptanoic acid;Prostaglandin  F1a;356,5;2-F07;2;ICCB Known Bioactives Library;745-62-0;PG010;1mM;Bioactive lipids:  Prostaglandin FP receptor agonist;DMSO;2840
;CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O;(5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoic acid;Prostaglandin F2a;354,5;2-F08;2;ICCB Known Bioactives Library;551-11-1;PG008;1mM;Bioactive lipids:  Prostaglandin FP receptor agonist;DMSO;2840
;CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H]2O\C(C[C@H]12)=C/CCCC(O)=O;5-[(2Z,3aR,4R,5R,6aS)-5-hydroxy-4-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-hexahydro-2H-cyclopenta[b]furan-2-ylidene]pentanoic acid;Prostaglandin I2 ;352,5;2-F09;2;ICCB Known Bioactives Library;61849-14-7;PG011;1mM;Bioactive lipids:  Prostaglandin IP receptor agonist;DMSO;2840
;CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](C\C=C/CCCC(O)=O)C=CC1=O;(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoic acid;Prostaglandin J2;334,4;2-F10;2;ICCB Known Bioactives Library;60203-57-8;PG033;1mM;Bioactive lipids:  Bioactive prostaglandin;DMSO;2840
;C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O;(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid;All trans retinoic acid;300,4;2-F11;2;ICCB Known Bioactives Library;302-79-4;GR100;1mM;Nuclear receptor ligands:  Retinoid RAR agonist;DMSO;2840
;CCCCCC(O)C1=CC(OCC2=NC3=CC=CC=C3C=C2)=CC=C1;1-[3-(quinolin-2-ylmethoxy)phenyl]hexan-1-ol;REV-5901;335,4;2-G02;2;ICCB Known Bioactives Library;101910-24-1;EI209;1mM;Lipid biosynthesis:  5-Lipoxygenase inhibitor;DMSO;2840
;COC(=O)[C@@H](N)CSC\C=C(/C)CC\C=C(/C)CCC=C(C)C;methyl (2R)-2-amino-3-{[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]sulfanyl}propanoate;S-farnesyl-L-cysteine;339,5;2-G03;2;ICCB Known Bioactives Library;;G201;1mM;Bioactive lipids:  MDR ATPase activator;DMSO;2840
;CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO;(2S,3R,4E)-2-aminooctadec-4-ene-1,3-diol;Sphingosine;299,5;2-G04;2;ICCB Known Bioactives Library;123-78-4;EI155;1mM;Bioactive lipids:  PKC inhibitor;DMSO;2840
;OC(=O)CCC\C=C/CC1C2CCC(O2)C1CNNC(=O)NC1=CC=CC=C1;(5Z)-7-[3-({[(phenylcarbamoyl)amino]amino}methyl)-7-oxabicyclo[2.2.1]heptan-2-yl]hept-5-enoic acid;SQ-29548;387,5;2-G05;2;ICCB Known Bioactives Library;98299-61-7;RA103;1mM;Bioactive lipids:  Thromboxane A2 antagonist;DMSO;2840
;CCCCCC1=CC2=C(C3C=C(CC[C@H]3C(C)(C)O2)C(O)=O)C(O)=C1;(6aR)-1-hydroxy-6,6-dimethyl-3-pentyl-6H,6aH,7H,8H,10aH-benzo[c]isochromene-9-carboxylic acid;Tetrahydrocannabinol-7-oic acid;344,4;2-G06;2;ICCB Known Bioactives Library;39690-06-7;L126;1mM;Nuclear receptor ligands:  PPAR gamma agonist;DMSO;2840
;C\C(=C/C1=CC=C(C=C1)C(O)=O)C1=CC2=C(C=C1)C(C)(C)CCC2(C)C;4-[(1E)-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-en-1-yl]benzoic acid;TTNPB;348,5;2-G07;2;ICCB Known Bioactives Library;71441-28-6;GR105;1mM;Nuclear receptor ligands:  Retinoid RAR agonist;DMSO;2840
;CCCCC[C@H](O)\C=C\[C@H]1[C@H]2C[C@H](CO2)[C@@H]1C\C=C/CCCC(O)=O;(5Z)-7-[(1R,4S,5S,6R)-6-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-2-oxabicyclo[2.2.1]heptan-5-yl]hept-5-enoic acid;U-46619;350,5;2-G08;2;ICCB Known Bioactives Library;56985-40-1;PG023;1mM;Bioactive lipids:  Thromboxane TP receptor agonist;DMSO;2840
;CCCCC\C=C/CC(O)\C=C\C1=CC=CC(CC(O)CCCCO)=N1;6-{6-[(1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl]pyridin-2-yl}hexane-1,5-diol;U-75302;361,5;2-G09;2;ICCB Known Bioactives Library;119477-85-9;RA102;0.1mM;Bioactive lipids:  Leukotriene B4 receptor antagonist;DMSO;2840
;CS(O)(=O)=O.CC1=C(C(=O)C2=C3C=CC=CC3=CC=C2)C2=C3N1[C@H](CN1CCOCC1)COC3=CC=C2;"(11R)-2-methyl-11-(morpholin-4-ylmethyl)-3-(naphthalene-1-carbonyl)-9-oxa-1-azatricyclo[6.3.1.0⁴,¹²]dodeca-2,4(12),5,7-tetraene; methanesulfonic acid";WIN 55,212-2 mesylate;522,6;2-G10;2;ICCB Known Bioactives Library;131543-23-2;CR105;1mM;CNS receptor ligands:  Cannabinoid CB1/CB2 receptor agonist;DMSO;2840
;CC1=CC=CC(NC2=NC(SCC(O)=O)=NC(Cl)=C2)=C1C;2-({4-chloro-6-[(2,3-dimethylphenyl)amino]pyrimidin-2-yl}sulfanyl)acetic acid;WY-14643;323,8;2-G11;2;ICCB Known Bioactives Library;50892-23-4;GR200;1mM;Nuclear receptor ligands:  PPAR alpha agonist;DMSO;2840
;NC1=CC=NC=C1;pyridin-4-amine;4-Aminopyridine;94,1;2-H02;2;ICCB Known Bioactives Library;504-24-5;AC119;5mg/mL;Ion channel ligands:  Potassium channels;DMSO;2840
;CCCCCC(O)CCCC(O)=O;5-hydroxydecanoic acid;5-Hydroxydecanoate;188,3;2-H03;2;ICCB Known Bioactives Library;624-00-0;KC141;10mM;Ion channel ligands:  Potassium channels;DMSO;2840
;[H][C@@]12C[C@@]3(O)[C@H](OC(=O)C4=CC=CC=C4)[C@]1([H])[C@](OC(C)=O)([C@@H](O)[C@@H]3OC)[C@@]1([H])[C@H](OC)C3C22[C@@H](C[C@@H](O)[C@@]3(COC)CN(CC)[C@]12[H])OC;(2R,3R,4R,5R,6S,7S,8R,9R,10R,13R,14R,16R,18R)-8-(acetyloxy)-11-ethyl-3,9,10-trihydrogenio-5,7,14-trihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate;Aconitine;645,7;2-H04;2;ICCB Known Bioactives Library;302-27-2;AC126;5mg/mL;Ion channel ligands:  Sodium channels;DMSO;2840
;Cl.CN(CCC1=CC(Cl)=C(Cl)C=C1)CC(O)COC1=CC=C(NS(C)(=O)=O)C=C1;N-[4-(3-{[2-(3,4-dichlorophenyl)ethyl](methyl)amino}-2-hydroxypropoxy)phenyl]methanesulfonamide hydrochloride;AM 92016·HCl;483,8;2-H05;2;ICCB Known Bioactives Library;178894-81-0;AC115;5mg/mL;Ion channel ligands:  Potassium channels;DMSO;2840
;Cl.NC12CC3CC(CC(C3)C1)C2;adamantan-1-amine hydrochloride;Amantadine·HCl;187,7;2-H06;2;ICCB Known Bioactives Library;665-66-7;AC133;5mg/mL;Ion channel ligands:  Misc. channels;DMSO;2840
;Cl.NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N;3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide hydrochloride;Amiloride·HCl;266,1;2-H07;2;ICCB Known Bioactives Library;2016-88-8;CA200;5mg/mL;Ion channel ligands:  Calcium channels;DMSO;2840
;Cl.CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2;{2-[4-(2-butyl-1-benzofuran-3-carbonyl)-2,6-diiodophenoxy]ethyl}diethylamine hydrochloride;Amiodarone·HCl;681,8;2-H08;2;ICCB Known Bioactives Library;19774-82-4;AC105;5mg/mL;Ion channel ligands:  Calcium channels;DMSO;2840
;CNC1=C(C(O)=O)C2=C(OC(C[C@@H]3OC4(CC[C@@H]3C)O[C@H](C(C)C(=O)C3=CC=CN3)[C@H](C)C[C@H]4C)=N2)C=C1;5-(methylamino)-2-{[(2S,3S,8S,9R,11R)-3,9,11-trimethyl-8-[1-oxo-1-(1H-pyrrol-2-yl)propan-2-yl]-1,7-dioxaspiro[5.5]undecan-2-yl]methyl}-1,3-benzoxazole-4-carboxylic acid;A-23187;523,6;2-H09;2;ICCB Known Bioactives Library;52665-69-7;CA100;5mg/mL;Ion channel ligands:  Calcium ionophore;DMSO;2840
;COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)C(F)(F)F)[N+]([O-])=O;methyl 2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3-carboxylate;(R)-(+)-BAY K-8644;356,3;2-H10;2;ICCB Known Bioactives Library;98791-67-4;CA410;5mg/mL;Ion channel ligands:  Calcium channels;DMSO;2840
;Cl.N\C(NC(=O)C1=NC(Cl)=C(N)N=C1N)=N/CC1=CC=CC=C1;3,5-diamino-N-[(E)-N'-benzylcarbamimidoyl]-6-chloropyrazine-2-carboxamide hydrochloride;Benzamil·HCl;356,2;2-H11;2;ICCB Known Bioactives Library;2898-76-2;NA103;10mM;Ion channel ligands:  Calcium channels;DMSO;2840
;Cl.CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1;N-benzyl-N-[3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl]aniline hydrochloride;Bepridil·HCl;403,0;3-A02;3;ICCB Known Bioactives Library;74764-40-2;AC104;5mg/mL;Ion channel ligands:  Calcium channels;DMSO;2840
;[H][C@@]12CC3=CC=CC4=C3C(=CN4)[C@]1([H])[C@]1([H])N(C(=O)\C(=C(\C)O)C1=O)C2(C)C;(2R,3S,5Z,9R)-5-(1-hydroxyethylidene)-8,8-dimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-1(17),11,13,15(18)-tetraene-4,6-dione;Cyclopiazonic acid;336,4;3-A03;3;ICCB Known Bioactives Library;18172-33-3;CA415;5mg/mL;Ion channel ligands:  Intracellular calcium;DMSO;2840
;[O-][N+](=O)C1=CC=C(C=C1)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O;1-[(E)-{[5-(4-nitrophenyl)furan-2-yl]methylidene}amino]imidazolidine-2,4-dione;Dantrolene;314,3;3-A04;3;ICCB Known Bioactives Library;7261-97-4;AC100;5mg/mL;Ion channel ligands:  Intracellular calcium;DMSO;2840
;CC1=NC2=CC=C(Cl)C=C2S(=O)(=O)N1;7-chloro-3-methyl-2H-1λ⁶,2,4-benzothiadiazine-1,1-dione;Diazoxide;230,7;3-A05;3;ICCB Known Bioactives Library;364-98-7;KC115;5mg/mL;Ion channel ligands:  Potassium channels;DMSO;2840
;Cl.N\C(NCC1=CC=C(Cl)C=C1Cl)=N/C(=O)C1=NC(Cl)=C(N)N=C1N;3,5-diamino-N-[(1E)-amino({[(2,4-dichlorophenyl)methyl]amino})methylidene]-6-chloropyrazine-2-carboxamide hydrochloride;Dichlorobenzamil·HCl;425,1;3-A06;3;ICCB Known Bioactives Library;1166-01-4;CA204;5mg/mL;Ion channel ligands:  Calcium channels;DMSO;2840
;Cl.[H][C@]1(OC(C)=O)C(=O)N(CCN(C)C)C2=C(S[C@@]1([H])C1=CC=C(OC)C=C1)C=CC=C2;(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate hydrochloride;Diltiazem·HCl;451,0;3-A07;3;ICCB Known Bioactives Library;33286-22-5;CA205;5mg/mL;Ion channel ligands:  Calcium channels;DMSO;2840
;CC1=CC=CC(CCN2CCC(CC2)C(=O)C2=CC=C(NS(C)(=O)=O)C=C2)=N1;N-(4-{1-[2-(6-methylpyridin-2-yl)ethyl]piperidine-4-carbonyl}phenyl)methanesulfonamide;E-4031;401,5;3-A08;3;ICCB Known Bioactives Library;113558-89-7;KC158;5mg/mL;Ion channel ligands:  Potassium channels;DMSO;2840
;NC1=C(C(=NN1C1=C(Cl)C=C(C=C1Cl)C(F)(F)F)C#N)S(=O)C(F)(F)F;5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-trifluoromethanesulfinyl-1H-pyrazole-3-carbonitrile;Fipronil;437,1;3-A09;3;ICCB Known Bioactives Library;120068-37-3;CM102;5mg/mL;Ion channel ligands:  Misc. channels;DMSO;2840
;CC([O-])=O.FC(F)(F)COC1=CC=C(OCC(F)(F)F)C(=C1)C(=O)NCC1CCCCN1;N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide acetate;Flecainide acetate;473,4;3-A10;3;ICCB Known Bioactives Library;54143-56-5;AC130;10mM;Ion channel ligands:  Sodium channels;Water;2840
;OC(=O)C1=CC=CC=C1NC1=CC(=CC=C1)C(F)(F)F;2-{[3-(trifluoromethyl)phenyl]amino}benzoic acid;Flufenamic acid;281,2;3-A11;3;ICCB Known Bioactives Library;530-78-9;AC123;5mg/mL;Ion channel ligands:  Potassium channels;DMSO;2840
;Cl.Cl.FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1;1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine dihydrochloride;Flunarizine·2HCl;477,4;3-B02;3;ICCB Known Bioactives Library;30484-77-6;CA225;5mg/mL;Ion channel ligands:  Calcium channels;DMSO;2840
;FC1=CC=C(C=C1)C(CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1)C1=CC=C(F)C=C1;8-[4,4-bis(4-fluorophenyl)butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;Fluspirilene;475,6;3-B03;3;ICCB Known Bioactives Library;1841-19-6;AC116;5mg/mL;Ion channel ligands:  Potassium channels;DMSO;2840
;COC(=O)C1=C(C)NC(C)=C1C(=O)C1=CC=CC=C1CC1=CC=CC=C1;methyl 4-(2-benzylbenzoyl)-2,5-dimethyl-1H-pyrrole-3-carboxylate;FPL-64176;347,4;3-B04;3;ICCB Known Bioactives Library;120934-96-5;CA245;5mg/mL;Ion channel ligands:  Calcium channels;DMSO;2840
;CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1;(5S)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one;6-Gingerol;294,4;3-B05;3;ICCB Known Bioactives Library;23513-14-6;CA422;5mg/mL;Ion channel ligands:  Intracellular calcium;DMSO;2840
;CC1=NC=C(N=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1;N-[2-(4-{[(cyclohexylcarbamoyl)amino]sulfonyl}phenyl)ethyl]-5-methylpyrazine-2-carboxamide;Glipizide;445,5;3-B06;3;ICCB Known Bioactives Library;29094-61-9;AC120;5mg/mL;Ion channel ligands:  Potassium channels;DMSO;2840
;COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1;5-chloro-N-[2-(4-{[(cyclohexylcarbamoyl)amino]sulfonyl}phenyl)ethyl]-2-methoxybenzamide;Glyburide;494,0;3-B07;3;ICCB Known Bioactives Library;10238-21-8;KC120;5mg/mL;Ion channel ligands:  Potassium channels;DMSO;2840
;[H][C@@]12C[C@H](O)C(C)(C)[C@@]1(O)[C@H](O)C[C@]13CC(C)(O)C(CC[C@@]1([H])[C@@]2(C)O)[C@H]3O;(1S,3R,4R,6S,8S,9R,10R,16R)-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,6,9,14,16-hexol;Grayanotoxin III;370,5;3-B08;3;ICCB Known Bioactives Library;4678-45-9;NA135;5mg/mL;Ion channel ligands:  Sodium channels;DMSO;2840
;C[C@]1(CC2=CC(OCC(O)=O)=C(Cl)C(Cl)=C2C1=O)C1CCCC1;2-{[(2S)-6,7-dichloro-2-cyclopentyl-2-methyl-1-oxo-2,3-dihydro-1H-inden-5-yl]oxy}acetic acid;R(+)-IAA-94;357,2;3-B09;3;ICCB Known Bioactives Library;54197-31-8;CM101;5mg/mL;Ion channel ligands:  Misc. channels;DMSO;2840
;Cl.[H][C@@]1(OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S[C@]1([H])C1=CC=C(OC)C=C1;(2R,3R)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate hydrochloride;L-cis-Diltiazem·HCl;451,0;3-B10;3;ICCB Known Bioactives Library;42399-54-2;CA207;5mg/mL;Ion channel ligands:  Calcium channels;DMSO;2840
;Cl.[H]O[H].CCN(CC)CC(=O)NC1=C(C)C=CC=C1C;2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide hydrate hydrochloride;Lidocaine·HCl·H2O;288,8;3-B11;3;ICCB Known Bioactives Library;6108-05-0;AC128;10mM;Ion channel ligands:  Sodium channels;DMSO;2840
;Cl.CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1;4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide hydrochloride;Loperamide·HCl;513,5;3-C02;3;ICCB Known Bioactives Library;34552-83-5;550-253;5mg/mL;Ion channel ligands:  Calcium channels;DMSO;2840
;Cl.COC1=CC=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C(OC)=C2)C=C1OC;5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)-2-(3,4,5-trimethoxyphenyl)pentanenitrile hydrochloride;Methoxyverapimil·HCl;521,1;3-C03;3;ICCB Known Bioactives Library;16662-47-8;AC103;10mM;Ion channel ligands:  Calcium channels;DMSO;2840
;NC1=[N+]([O-])C(N)=NC(=C1)N1CCCCC1;2,6-diamino-4-(piperidin-1-yl)pyrimidin-1-ium-1-olate;Minoxidil;209,2;3-C04;3;ICCB Known Bioactives Library;38304-91-5;KC125;5mg/mL;Ion channel ligands:  Potassium channels;DMSO;2840
;NC1=[N+](OS([O-])(=O)=O)C(N)=NC(=C1)N1CCCCC1;2,6-diamino-4-(piperidin-1-yl)-1-(sulfonatooxy)pyrimidin-1-ium;Minoxidil sulfate;289,3;3-C05;3;ICCB Known Bioactives Library;83701-22-8;KC130;5mg/mL;Ion channel ligands:  Potassium channels;DMSO;2840
;Cl.COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1;3-{2-[benzyl(methyl)amino]ethyl} 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride;Nicardipine·HCl;516,0;3-C06;3;ICCB Known Bioactives Library;54527-84-3;AC108;5mg/mL;Ion channel ligands:  Calcium channels;DMSO;2840
;CC(=O)OC1=C(C)NC(C)=C(OC(C)=O)C1C1=CC=CC=C1[N+]([O-])=O;5-(acetyloxy)-2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridin-3-yl acetate;Nifedipine;346,3;3-C07;3;ICCB Known Bioactives Library;21829-25-4;CA210;5mg/mL;Ion channel ligands:  Calcium channels;DMSO;2840
;OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)N=CC=C1;2-{[3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid;Niflumic acid;282,2;3-C08;3;ICCB Known Bioactives Library;4394-00-7;AC134;5mg/mL;Ion channel ligands:  Misc. channels;DMSO;2840
;Cl.COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCCN1CCC(CC1)(C1=CC=CC=C1)C1=CC=CC=C1;3-[3-(4,4-diphenylpiperidin-1-yl)propyl] 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride;Niguldipine;646,2;3-C09;3;ICCB Known Bioactives Library;113317-61-6;CA216;5mg/mL;Ion channel ligands:  Calcium channels;DMSO;2840
;COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)OC(C)C;3-(2-methoxyethyl) 5-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;Nimodipine;418,4;3-C10;3;ICCB Known Bioactives Library;66085-59-4;550-277;5mg/mL;Ion channel ligands:  Calcium channels;DMSO;2840
;CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)OC;3-ethyl 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;Nitrendipine;360,4;3-C11;3;ICCB Known Bioactives Library;39562-70-4;550-278;5mg/mL;Ion channel ligands:  Calcium channels;DMSO;2840
;OC(=O)C1=C(NC2=CC=CC=C2)C=CC=C1;2-(phenylamino)benzoic acid;N-Phenylanthranilic acid;213,2;3-D02;3;ICCB Known Bioactives Library;91-40-7;AC132;5mg/mL;Ion channel ligands:  Misc. channels;DMSO;2840
;OC(=O)C1=CC(=CC=C1NCCCC1=CC=CC=C1)[N+]([O-])=O;5-nitro-2-[(3-phenylpropyl)amino]benzoic acid;NPPB;300,3;3-D03;3;ICCB Known Bioactives Library;107254-86-4;CM100;5mg/mL;Ion channel ligands:  Misc. channels;DMSO;2840
;OC1=CC=C(C=C1N1C(=O)NC2=CC(=CC=C12)C(F)(F)F)C(F)(F)F;1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2,3-dihydro-1H-1,3-benzodiazol-2-one;NS-1619;362,2;3-D04;3;ICCB Known Bioactives Library;153587-01-0;KC127;5mg/mL;Ion channel ligands:  Potassium channels;DMSO;2840
;[H][C@]12CC3=C(NC4=CC=CC=C34)[C@]1(C)[C@@]1(C)CC[C@]3([H])O[C@@H](C(=O)C=C3[C@]1(O)CC2)C(C)(C)O;(1S,2R,5S,7R,11S,14S)-11-hydroxy-7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaen-8-one;Paxilline;435,6;3-D05;3;ICCB Known Bioactives Library;57186-25-1;KC155;5mg/mL;Ion channel ligands:  Potassium channels;DMSO;2840
;CC1(C)OC2=CC=C(C=C2[C@@H](OC2=CC(=O)CC2)[C@@H]1O)C#N;(3S,4R)-3-hydroxy-2,2-dimethyl-4-[(3-oxocyclopent-1-en-1-yl)oxy]-3,4-dihydro-2H-1-benzopyran-6-carbonitrile;PCO-400;299,3;3-D06;3;ICCB Known Bioactives Library;121055-10-5;KC131;5mg/mL;Ion channel ligands:  Potassium channels;DMSO;2840
;[H][C@]12O[C@@]11[C@]([H])(CC[C@]3(C)[C@@]4(C)C5=C6C7=C8C(CC(=C)[C@@]9([H])C[C@@]([H])([C@@]89O)C(C)(C)O[C@@]6([H])[C@]4([H])CC[C@@]13O)=C(Cl)C=C7N5)O[C@@]([H])([C@@H]2O)C(C)=C;(1S,2R,5S,6S,8R,9S,10R,12S,15R,16S,25R,27S,28R)-21-chloro-15,16,33,33-tetramethyl-24-methylidene-10-(prop-1-en-2-yl)-7,11,32-trioxa-18-azadecacyclo[25.4.2.0²,¹⁶.0⁵,¹⁵.0⁶,⁸.0⁶,¹².0¹⁷,³¹.0¹⁹,³⁰.0²²,²⁹.0²⁵,²⁸]tritriaconta-17(31),19,21,29-tetraene-5,9,28-triol;Penitrem A;634,2;3-D07;3;ICCB Known Bioactives Library;12627-35-9;KC157;5mg/mL;Ion channel ligands:  Potassium channels;DMSO;2840
;NC1=NC(N)=C(N=C1Cl)C(=O)NC(=N)NC1=CC=CC=C1;3,5-diamino-6-chloro-N-(N-phenylcarbamimidoyl)pyrazine-2-carboxamide;Phenamil;305,7;3-D08;3;ICCB Known Bioactives Library;2038-35-9;AC131;10mM;Ion channel ligands:  Sodium channels;DMSO;2840
;CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC=CC(O)=C1;3-[(4,5-dihydro-1H-imidazol-2-ylmethyl)(4-methylphenyl)amino]phenol;Phentolamine;281,4;3-D09;3;ICCB Known Bioactives Library;73-05-2;AC121;5mg/mL;Ion channel ligands:  Potassium channels;DMSO;2840
;O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1;5,5-diphenylimidazolidine-2,4-dione;Phenytoin;252,3;3-D10;3;ICCB Known Bioactives Library;57-41-0;AC125;5mg/mL;Ion channel ligands:  Sodum channels;DMSO;2840
;FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1;1-{1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one;Pimozide;461,5;3-D11;3;ICCB Known Bioactives Library;2062-78-4;AC109;10mM;Ion channel ligands:  Calcium channels;DMSO;2840
;CC(N\C(NC1=CC=NC=C1)=N/C#N)C(C)(C)C;(E)-2-cyano-1-(3,3-dimethylbutan-2-yl)-3-(pyridin-4-yl)guanidine;Pinacidil;245,3;3-E02;3;ICCB Known Bioactives Library;85371-64-8;AC118;10mM;Ion channel ligands:  Potassium channels;DMSO;2840
;CCN(CC)CCNC(=O)C1=CC=C(N)C=C1;4-amino-N-[2-(diethylamino)ethyl]benzamide;Procainamide;235,3;3-E03;3;ICCB Known Bioactives Library;614-39-1;AC127;5mg/mL;Ion channel ligands:  Sodium channels;DMSO;2840
;CCCNCC(O)COC1=CC=CC=C1C(=O)CCC1=CC=CC=C1;1-{2-[2-hydroxy-3-(propylamino)propoxy]phenyl}-3-phenylpropan-1-one;Propafenone;341,4;3-E04;3;ICCB Known Bioactives Library;54063-53-5;AC124;5mg/mL;Ion channel ligands:  Potassium channels;DMSO;2840
;Cl.[H]O[H].[H]C(O)(C1=CC=NC2=CC=C(OC)C=C12)[C@@]1([H])CC2CC[N@@]1C[C@]2([H])C=C;[(1R,2R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methanol hydrate hydrochloride;Quinidine·HCl·H2O;378,9;3-E05;3;ICCB Known Bioactives Library;6151-40-2;AC129;5mg/mL;Ion channel ligands:  Sodium channels;DMSO;2840
;Cl.[H]O[H].[H]O[H].[H][C@](O)(C1=CC=NC2=C1C=C(OC)C=C2)[C@]1([H])CC2CC[N@@]1CC2([H])C=C;(S)-[(1R,2S)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methanol dihydrate hydrochloride;Quinine·HCl·2H2O;396,9;3-E06;3;ICCB Known Bioactives Library;6119-47-7;AC122;5mg/mL;Ion channel ligands:  Potassium channels;DMSO;2840
;[Br-].CC[N+](CC)(CC)CC(=O)NC1=C(C)C=CC=C1C;{[(2,6-dimethylphenyl)carbamoyl]methyl}triethylazanium bromide;QX-314;343,3;3-E07;3;ICCB Known Bioactives Library;21306-56-9;NA134;5mg/mL;Ion channel ligands:  Sodium channels;DMSO;2840
;CC(C)[C@]1(O)[C@@H](OC(=O)C2=CC=CN2)[C@@]2(O)[C@@]3(C)C[C@]4(O)O[C@@]5([C@H](O)[C@@H](C)CC[C@]35O)[C@@]2(O)[C@@]14C;(1R,2R,3S,6S,7S,9S,10R,11R,12R,13S,14R)-2,6,9,11,13,14-hexahydroxy-3,7,10-trimethyl-11-(propan-2-yl)-15-oxapentacyclo[7.5.1.0¹,⁶.0⁷,¹³.0¹⁰,¹⁴]pentadecan-12-yl 1H-pyrrole-2-carboxylate;Ryanodine;493,5;3-E08;3;ICCB Known Bioactives Library;15662-33-6;CA450;5mg/mL;Ion channel ligands:  Intracellular calcium;DMSO;2840
;OC(COC1=C2C=C(NC2=CC=C1)C#N)CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1;4-{3-[4-(diphenylmethyl)piperazin-1-yl]-2-hydroxypropoxy}-1H-indole-2-carbonitrile;SDZ-201106;466,6;3-E09;3;ICCB Known Bioactives Library;97730-95-5;NA116;5mg/mL;Ion channel ligands:  Sodium channels;DMSO;2840
;COC1=CC=C(CCCOC(CN2C=CN=C2)C2=CC=C(OC)C=C2)C=C1;1-[2-(4-methoxyphenyl)-2-[3-(4-methoxyphenyl)propoxy]ethyl]-1H-imidazole;SKF-96365;366,5;3-E10;3;ICCB Known Bioactives Library;130495-35-1;CA230;5mg/mL;Ion channel ligands:  Calcium channels;DMSO;2840
;[H][C@]12CC3=CC=C(OC4=CC(C[C@]5([H])N(C)CCC6=C5C(OC5=CC1=C(CCN2C)C=C5OC)=C(OC)C(OC)=C6)=CC=C4OC)C=C3;(1S,14S)-9,20,21,25-tetramethoxy-15,30-dimethyl-7,23-dioxa-15,30-diazaheptacyclo[22.6.2.2³,⁶.1⁸,¹².1¹⁴,¹⁸.0²⁷,³¹.0²²,³³]hexatriaconta-3,5,8(34),9,11,18(33),19,21,24(32),25,27(31),35-dodecaene;Tetrandine;622,7;3-E11;3;ICCB Known Bioactives Library;518-34-3;CA260;5mg/mL;Ion channel ligands:  Calcium channels;DMSO;2840
;[H][C@]12[C@H](OC(=O)CCCCCCC)[C@@H](OC(=O)C(\C)=C/C)C(C)=C1[C@@H]1OC(=O)[C@@](C)(O)[C@@]1(O)[C@H](C[C@]2(C)OC(C)=O)OC(=O)CCC;(3S,3aR,4S,6S,6aR,7S,8S,9bS)-6-(acetyloxy)-4-(butanoyloxy)-3,3a-dihydroxy-3,6,9-trimethyl-8-{[(2Z)-2-methylbut-2-enoyl]oxy}-2-oxo-2H,3H,3aH,4H,5H,6H,6aH,7H,8H,9bH-azuleno[4,5-b]furan-7-yl octanoate;Thapsigargin;650,8;3-F02;3;ICCB Known Bioactives Library;67526-95-8;PE180;5mg/mL;Ion channel ligands:  Intracellular calcium;DMSO;2840
;CCN(CC)CCCCCCCCOC(=O)C1=CC(OC)=C(OC)C(OC)=C1;8-(diethylamino)octyl 3,4,5-trimethoxybenzoate;TMB-8;395,5;3-F03;3;ICCB Known Bioactives Library;53464-72-5;EI110;5mg/mL;Ion channel ligands:  Intracellular calcium;DMSO;2840
;CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CCCCCC1;1-(azepan-1-yl)-3-(4-methylbenzenesulfonyl)urea;Tolazamide;311,4;3-F04;3;ICCB Known Bioactives Library;1156-19-0;KC135;5mg/mL;Ion channel ligands:  Potassium channels;DMSO;2840
;CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1;3-butyl-1-(4-methylbenzenesulfonyl)urea;Tolbutamide;270,3;3-F05;3;ICCB Known Bioactives Library;64-77-7;AC117;5mg/mL;Ion channel ligands:  Potassium channels;DMSO;2840
;C1CCC(CC1)\N=C(/NC1C2CC3CC(C2)CC1C3)N1CCOCC1;(E)-N-(adamantan-2-yl)-N'-cyclohexylmorpholine-4-carboximidamide;U-37883A;345,5;3-F06;3;ICCB Known Bioactives Library;57568-80-6;KC159;5mg/mL;Ion channel ligands:  Potassium channels;DMSO;2840
;CN([C@H]1CCCC[C@@H]1N1CCCC1)C(=O)CC1=CC=C(Cl)C(Cl)=C1;2-(3,4-dichlorophenyl)-N-methyl-N-[(1S,2S)-2-(pyrrolidin-1-yl)cyclohexyl]acetamide;U-50488;369,3;3-F07;3;ICCB Known Bioactives Library;67198-13-4;N701;5mg/mL;Ion channel ligands:  Calcium channels;DMSO;2840
;COC1=CC=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1OC;2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile;Verapimil;454,6;3-F08;3;ICCB Known Bioactives Library;23313-68-0;550-306;5mg/mL;Ion channel ligands:  Calcium channels;DMSO;2840
;[H][C@@]12CC[C@@]3([H])[C@]4(O)C[C@H](O)[C@@]5(O)[C@@]([H])(CN6C[C@@H](C)CC[C@@]6([H])[C@@]5(C)O)[C@]4(O)C[C@@]33O[C@]1(O)[C@H](CC[C@@]23C)OC(=O)C1=CC=C(OC)C(OC)=C1;(1R,2S,6S,9S,10R,11S,12S,14R,15S,18S,19S,22S,23S,25R)-18-hydrogenio-1,10,11,12,14,23-hexahydroxy-6,10,19-trimethyl-24-oxa-4-azaheptacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁵.0¹⁸,²³.0¹⁹,²⁵]hexacosan-22-yl 3,4-dimethoxybenzoate;Veratridine;673,8;3-F09;3;ICCB Known Bioactives Library;71-62-5;NA125;5mg/mL;Ion channel ligands:  Sodium channels;DMSO;2840
;COC1=C(OC)C=C(CCN(C)CCC2=CC(OC)=C(OC)C=C2)C=C1;bis[2-(3,4-dimethoxyphenyl)ethyl](methyl)amine;YS035;359,5;3-F10;3;ICCB Known Bioactives Library;33978-72-2;AC106;5mg/mL;Ion channel ligands:  Calcium channels;DMSO;2840
;CC(O)(C(=O)NC1=CC=C(C=C1)S(=O)(=O)C1=CC=CC=C1)C(F)(F)F;N-[4-(benzenesulfonyl)phenyl]-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide;ZM226600;373,3;3-F11;3;ICCB Known Bioactives Library;147695-92-9;KC170;5mg/mL;Ion channel ligands:  Potassium channels;DMSO;2840
;CC1=CC=C(C=C1)S(=O)(=O)N[C@@H](CC1=CC=CC=C1)C(=O)CCl;(2S)-4-chloro-S-(4-methylphenyl)-3-oxo-1-phenylbutane-2-sulfonamido;Tosyl-Phe-CMK (TPCK);351,8;3-G02;3;ICCB Known Bioactives Library;402-71-1;PI122;5mg/mL;Protease inhibitors:  Serine protease inhibitor;DMSO;2840
;OC(=O)CNC(=O)C(CS)CC1=CC=CC=C1;2-(2-benzyl-3-sulfanylpropanamido)acetic acid;Thiorphan;253,3;3-G03;3;ICCB Known Bioactives Library;76721-89-6;PI113;5mg/mL;Protease inhibitors:  Neutral endopeptidase inhibitor;DMSO;2840
;O=C[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)OCC1=CC=CC=C1;benzyl (2S)-2-[(2S)-2-formylpyrrolidine-1-carbonyl]pyrrolidine-1-carboxylate;Z-prolyl-prolinal;330,4;3-G04;3;ICCB Known Bioactives Library;86925-97-5;PI112;5mg/mL;Protease inhibitors:  Prolyl endopeptidase inhibitor;DMSO;2840
;[H]C(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@@H](NS(=O)(=O)C1=CC=CC2=C1C=CC=C2)C(C)CC;(2S)-N-[(2S)-1-(1H-indol-3-yl)-3-oxopropan-2-yl]-3-methyl-2-(naphthalene-1-sulfonamido)pentanamide;NapSul-Ile-Trp-CHO;491,6;3-G05;3;ICCB Known Bioactives Library;161709-56-4;PI125;5mg/mL;Protease inhibitors:  Cathepsin L inhibitor;DMSO;2840
;ClC1=C(Cl)C2=CC=CC=C2C(=O)O1;3,4-dichloro-1H-isochromen-1-one;3,4-dichloroisocoumarin;215,0;3-G06;3;ICCB Known Bioactives Library;51050-59-0;PI110;10mM;Protease inhibitors:  Granzyme B inhibitor;DMSO;2840
;[H]C(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)OC(C)(C)C)C(C)C)C(C)C;tert-butyl N-({[(1S)-2-methyl-1-{[(2S)-3-methyl-1-oxobutan-2-yl]carbamoyl}propyl]carbamoyl}methyl)carbamate;Boc-GVV-CHO;357,4;3-G07;3;ICCB Known Bioactives Library;914769-15-6;PI128;5mg/mL;Protease inhibitors:  Gamma secretase inhibitor;DMSO;2840
;CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1)C(O)=O;(2S)-2-[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanamido]-4-methylpentanoic acid;Bestatin;308,4;3-G08;3;ICCB Known Bioactives Library;65391-42-6;EI212;5mg/mL;Protease inhibitors:  Aminopeptidase inhibitor;DMSO;2840
;C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)CCl;(2S)-2-[(2S)-2-aminopropanamido]-N-[(2S)-4-chloro-3-oxo-1-phenylbutan-2-yl]propanamide;Ala-Ala-Phe-CMK;339,8;3-G09;3;ICCB Known Bioactives Library;102129-66-8;PI123;5mg/mL;Protease inhibitors:  Tripeptidyl peptidase II inhibitor;DMSO;2840
;[H]C(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)OCC1=CC=CC=C1)C(C)C;benzyl N-[(1S)-2-methyl-1-{[(2S)-1-oxo-3-phenylpropan-2-yl]carbamoyl}propyl]carbamate;MDL-28170;382,5;3-G10;3;ICCB Known Bioactives Library;88191-84-8;PI130;5mg/mL;Protease inhibitors:  Calpain inhibitor;DMSO;2840
;[H]C(=O)[C@H](CCCC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O;(2S)-2-[(2S)-2-acetamido-4-methylpentanamido]-4-methyl-N-[(2S)-1-oxohexan-2-yl]pentanamide;Ac-Leu-Leu-Nle-CHO;383,5;3-G11;3;ICCB Known Bioactives Library;110044-82-1;P120;5mg/mL;Protease inhibitors:  Calpain inhibitor;DMSO;2840
;[H]C(=O)NC1=CC=CC(C(=O)N[C@H]2[C@@H](C)OC(=O)[C@H](CCCC)[C@@H](OC(=O)CC(C)C)[C@H](C)OC2=O)=C1OC;(2R,3S,6S,7R,8R)-8-butyl-3-(3-formamido-2-methoxybenzamido)-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl 3-methylbutanoate;2-methoxyantimycin A3;534,6;3-H02;3;ICCB Known Bioactives Library;868862-13-9;CM123;5mg/mL;Inhibitors:  Bcl-2/Bcl-XL ligand induces apoptosis;DMSO;2840
;ClC1=CC=C(C=C1)C12CC3CC(CC(C3)(C1)C(=O)NCC1=CC=NC=C1)C2;3-(4-chlorophenyl)-N-(pyridin-4-ylmethyl)adamantane-1-carboxamide;ABC294640;380,9;3-H03;3;ICCB Known Bioactives Library;915385-81-8;AC1800;5mg/mL;SK2 inhib.;DMSO;2840
;CCCCCCCCCCC1=C(C)C(=O)C(OC)=C(OC)C1=O;2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione;Decylubiquinone;322,4;3-H04;3;ICCB Known Bioactives Library;55486-00-5;CM115;5mg/mL;Inhibitors:  inhibits mitochondrial permeability pore opening ;DMSO;2840
;[H][C@]12[C@@H](CC[C@@]1(CC[C@]1(C)[C@]2([H])CC[C@]2([H])[C@@]3(C)CC[C@H](O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O)C(C)=C;(1R,2R,5S,8R,9R,10R,13R,14R,17S,19R)-17-hydroxy-1,2,14,18,18-pentamethyl-8-(prop-1-en-2-yl)pentacyclo[11.8.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]henicosane-5-carboxylic acid;Betulinic acid;456,7;3-H05;3;ICCB Known Bioactives Library;472-15-1;AP301 ;5mg/mL;Inhibitors:  induces mitochondrial permeability pore opening;DMSO;2840
;[H]C#CCN(C)[C@H](C)CC1=CC=CC=C1;methyl[(2R)-1-phenylpropan-2-yl](prop-2-yn-1-yl)amine;Deprenyl;187,3;3-H06;3;ICCB Known Bioactives Library;14611-52-0;EI240;5mg/ml;Inhibitors:  inhibits glyceraldehyde-3-phosphate dehydrogenase;DMSO;2840
;Cl.Cl.CC(=N)NCC1=CC=CC(CN)=C1;N-{[3-(aminomethyl)phenyl]methyl}ethanimidamide dihydrochloride;1400W·2HCl;250,2;3-H07;3;ICCB Known Bioactives Library;214358-33-5;CN268;5mg/mL;Inhibitors:  iNOS inhibitor;DMSO;2840
;CCCC[C@@H](C)[C@@H](OC(=O)C[C@@H](CC(O)=O)C(O)=O)[C@H](C[C@@H](C)C[C@H](O)CCCC[C@@H](O)C[C@H](O)[C@H](C)N)OC(=O)C[C@H](CC(O)=O)C(O)=O;(2S)-2-(2-{[(5R,6R,7S,9S,11R,16R,18S,19S)-19-amino-6-{[(3R)-3,4-dicarboxybutanoyl]oxy}-11,16,18-trihydroxy-5,9-dimethylicosan-7-yl]oxy}-2-oxoethyl)butanedioic acid;Fumonisin B1;721,8;3-H08;3;ICCB Known Bioactives Library;116355-83-0;SL220;5mg/mL;Lipid biosynthesis:  inhibits ceramide synthase;DMSO;2840
;[H][C@@]12C[C@@H]3O[C@@]33[C@H](O)[C@]4(O[C@H]4[C@@H]4O[C@]34[C@@]1(C)CCC1=C2COC1=O)C(C)C;(1S,2S,4S,5S,7R,8R,9S,11S,13S)-8-hydroxy-1-methyl-7-(propan-2-yl)-3,6,10,16-tetraoxaheptacyclo[11.7.0.0²,⁴.0²,⁹.0⁵,⁷.0⁹,¹¹.0¹⁴,¹⁸]icos-14(18)-en-17-one;Triptolide;360,4;3-H09;3;ICCB Known Bioactives Library;38748-32-2;AP304;5mg/mL;Inhibitors:  inhibits NFkappaB transcriptional activation;DMSO;2840
;CC1=COC2=C1C(=O)C(=O)C1=C2C=CC2=C1CCCC2(C)C;6,6,14-trimethyl-12-oxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-1(10),2(7),8,11(15),13-pentaene-16,17-dione;Tanshinone IIA;294,3;3-H10;3;ICCB Known Bioactives Library;568-72-9;GR336;5mg/mL;Inhibitors:  AP-1 inhibitor;DMSO;2840
;[H][C@@]1(C[C@H](C)[C@@]([H])(O1)[C@]1(C)CC[C@@]([H])(O1)[C@]1(C)C[C@@H](C)[C@]2(O1)O[C@]([H])(C[C@@]1([H])CC[C@H](C)[C@@]([H])(O1)[C@@H](C)C(O)=O)C[C@@H](OC)[C@H]2C)[C@@]1([H])O[C@@](O)(CO)[C@H](C)C[C@@H]1C;(2R)-2-[(2R,3S,6R)-6-{[(2S,4R,5R,7R,9R,10R)-2-[(2R,5S)-5-[(2R,3S,5R)-5-[(2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]-5-methyloxolan-2-yl]-9-methoxy-2,4,10-trimethyl-1,6-dioxaspiro[4.5]decan-7-yl]methyl}-3-methyloxan-2-yl]propanoic acid;Nigericin;725,0;3-H11;3;ICCB Known Bioactives Library;28380-24-7;CA421;5mg/mL;Inhibitors:  induces intracellular acidification;DMSO;2840
;[H][C@@]12N3CCC1=C[C@H](O)[C@@H](O)[C@@]2([H])C1=CC2=C(OCO2)C=C1C3;(1S,17S,18S,19S)-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,15-tetraene-17,18-diol;Lycorine;287,3;4-A02;4;ICCB Known Bioactives Library;476-28-8;GR313;5mg/mL;Inhibitors:  inhibits TNFalpha production;DMSO;2840
;CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(O)C=CC=C4N=C13)C2=O;(19S)-19-ethyl-8,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione;10-hydroxycamptothecin;364,4;4-A03;4;ICCB Known Bioactives Library;64439-81-2;GR316;2mg/mL;Inhibitors:  topoisomerase 1 inhibitor;DMSO;2840
;CC1(C)CCC2=C(O1)C1=CC=CC=C1C(=O)C2=O;2,2-dimethyl-2H,3H,4H,5H,6H-naphtho[1,2-b]pyran-5,6-dione;Beta-lapachone;242,3;4-A04;4;ICCB Known Bioactives Library;4707-32-8;GR308;5mg/mL;Inhibitors:  topoisomerase 1 inhibitor;DMSO;2840
;C\C1=C/CC[C@@]2(C)O[C@@H]2[C@H]2OC(=O)C(=C)[C@@H]2CC1;(1S,2R,4R,7E,11S)-4,8-dimethyl-12-methylidene-3,14-dioxatricyclo[9.3.0.0²,⁴]tetradec-7-en-13-one;Parthenolide;248,3;4-A05;4;ICCB Known Bioactives Library;20554-84-1;T113;5mg/mL;Inhibitors:  IkappaB kinase inhibitor;DMSO;2840
;[H]C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1;benzyl N-[(1S)-3-methyl-1-{[(1S)-3-methyl-1-{[(2S)-4-methyl-1-oxopentan-2-yl]carbamoyl}butyl]carbamoyl}butyl]carbamate;MG-132;475,6;4-A06;4;ICCB Known Bioactives Library;133407-82-6;PI102;10mM;Protease inhibitors:  Proteasome inhibitor;DMSO;2840
;NC1=CC2=C(C=C1)N=CN=C2NCCC1=CC=C(OC2=CC=CC=C2)C=C1;4-N-[2-(4-phenoxyphenyl)ethyl]quinazoline-4,6-diamine;QNZ;356,4;4-A07;4;ICCB Known Bioactives Library;545380-34-5;EI352;5mg/mL;Inhibitors:  NFkappaB inhibitor;DMSO;2840
;CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O;2-(4-{2-[(4-chlorophenyl)formamido]ethyl}phenoxy)-2-methylpropanoic acid;bezafibrate;361,8;4-A08;4;ICCB Known Bioactives Library;41859-67-0;GR211;5mg/mL;Nuclear receptor ligands:  PPAR alpha agonist;DMSO;2840
;CCOC(=O)CN1C(=O)CC(C[C@@H](O)C2C[C@@H](C)C[C@H](C)C2=O)CC1=O;ethyl 2-{4-[(2R)-2-[(3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]-2,6-dioxopiperidin-1-yl}acetate;Cycloheximide-N-ethylethanoate;367,4;4-A09;4;ICCB Known Bioactives Library;1228542-21-9;IM100;5mg/mL;Inhibitors:  FKBP12 inhibitor;DMSO;2840
;[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@H]1C(=O)O[C@@H]([C@H](C)[C@@H](O)CC(=O)[C@H](CC)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@@H](O)[C@@H](C1)OC;(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-17-ethyl-24-hydrogenio-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0⁴,⁹]octacos-18-ene-2,3,10,16-tetrone;Ascomycin (FK-520);792,0;4-A10;4;ICCB Known Bioactives Library;11011-38-4;A165;5mg/mL;Inhibitors:  binds to FKBP inhibits calcineurin;DMSO;2840
;[H][C@@]1(CCC2C3CCC4=CC(=O)C=CC4(C)C3=CCC12C)C(=O)CN1CCN(CC1)C1=CC(=NC(=N1)N1CCCC1)N1CCCC1;(14S)-14-(2-{4-[2,6-bis(pyrrolidin-1-yl)pyrimidin-4-yl]piperazin-1-yl}acetyl)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-1(17),3,6-trien-5-one;U-74389G;610,8;4-A11;4;ICCB Known Bioactives Library;153190-29-5;FR100;10mM;Inhibitors:  superoxide/free-radical inhibitor;DMSO;2840
;O=C1N([Se]C2=CC=CC=C12)C1=CC=CC=C1;2-phenyl-2,3-dihydro-1,2-benzoselenazol-3-one;Ebselen;274,2;4-B02;4;ICCB Known Bioactives Library;60940-34-3;EI207;10mM;Inhibitors:  glutathione peroxidase mimetic;DMSO;2840
;FC(F)(F)C1=CC=CC=C1N1C=CN=C1;1-[2-(trifluoromethyl)phenyl]-1H-imidazole;TRIM;212,2;4-B03;4;ICCB Known Bioactives Library;25371-96-4;CN266;5mg/mL;Inhibitors:  bNOS/iNOS inhibitor;DMSO;2840
;COC1=CC(=CC=C1OC(F)F)C1=NNC(=O)C=C1;6-[4-(difluoromethoxy)-3-methoxyphenyl]-2,3-dihydropyridazin-3-one;Zardaverine;268,2;4-B04;4;ICCB Known Bioactives Library;101975-10-4;PD195;5mg/mL;Inhibitors:  phosphodiesterase (PDE1/2) inhibitor;DMSO;2840
;CCCOC1=CC=CC=C1C1=NC2=C(N=NN2)C(=O)N1;5-(2-propoxyphenyl)-3H,6H,7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one;Zaprinast;271,3;4-B05;4;ICCB Known Bioactives Library;37762-06-4;PD190;10mM;Inhibitors:  phosphodiesterase (PDE1) inhibitor;DMSO;2840
;[H][C@]12N3CCC[C@@]1(CC)C=C(N1C4=C(C=CC=C4)C(CC3)=C21)C(=O)OCC;ethyl (15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2(7),3,5,8(18),16-pentaene-17-carboxylate;Vinpocetine;350,5;4-B06;4;ICCB Known Bioactives Library;42971-09-5;PD185;10mM;Inhibitors:  phosphodiesterase (PDE1) inhibitor;DMSO;2840
;COC1=C(OC)C=C2C(CCN3C(=O)N(C)C(C=C23)=NC2=C(C)C=C(C)C=C2C)=C1;9,10-dimethoxy-3-methyl-2-[(2,4,6-trimethylphenyl)imino]-2H,3H,4H,6H,7H-pyrimido[4,3-a]isoquinolin-4-one;Trequinsin;405,5;4-B07;4;ICCB Known Bioactives Library;78416-81-6;PD180;10mM;Inhibitors:  phosphodiesterase (PDE3) inhibitor;DMSO;2840
;CN\C(NC#N)=N/C1=CC=C(C=C1)C1=NNC(=O)CC1C;(E)-3-cyano-1-methyl-2-[4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl]guanidine;Siguazodan;284,3;4-B08;4;ICCB Known Bioactives Library;115344-47-3;PD179;5mg/mL;Inhibitors:  phosphodiesterase (PDE3) inhibitor;DMSO;2840
;COC1=CC=C(C=C1OC1CCCC1)C1CNC(=O)C1;4-[3-(cyclopentyloxy)-4-methoxyphenyl]pyrrolidin-2-one;Rolipram;275,3;4-B09;4;ICCB Known Bioactives Library;61413-54-5;PD175;10mM;Inhibitors:  phosphodiesterase (PDE4 ) inhibitor;DMSO;2840
;CCCCOC1=CC(CC2CNC(=O)N2)=CC=C1OC;4-[(3-butoxy-4-methoxyphenyl)methyl]imidazolidin-2-one;Ro 20-1724;278,3;4-B10;4;ICCB Known Bioactives Library;29925-17-5;EI117;5mg/mL;Inhibitors:  phosphodiesterase (PDE4 ) inhibitor;DMSO;2840
;ClC1=CC(NC2=C3C=CC=CC3=C(N=N2)C2=CC=CC=C2)=CC=C1;N-(3-chlorophenyl)-4-phenylphthalazin-1-amine;MY-5445;331,8;4-B11;4;ICCB Known Bioactives Library;78351-75-4;PD155;5mg/mL;Inhibitors:  phosphodiesterase (PDE5) inhibitor;DMSO;2840
;NCCNS(=O)(=O)C1=CC=CC2=C(Cl)C=CC=C12;N-(2-aminoethyl)-5-chloronaphthalene-1-sulfonamide;A-3;284,8;4-C02;4;ICCB Known Bioactives Library;78957-85-4;EI145;5mg/mL;Kinase inhibitors:  kinase inhibitor;DMSO;2840
;CC(C)=CCC\C(C)=C\CC\C(C)=C\CSC[C@H](NC(C)=O)C(O)=O;(2S)-2-acetamido-3-{[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]sulfanyl}propanoic acid;Acetyl (N)-s-farnesyl-l-cysteine;367,5;4-C03;4;ICCB Known Bioactives Library;135304-07-3;G200;5mg/mL;Inhibitors:  farnesylation inhibitor;DMSO;2840
;CC1=C2OC3=C(C)C(=O)C(N)=C(C(=O)C4CCCCO4)C3=NC2=C(C=C1)C(=O)C1CCCCO1;2-amino-4,6-dimethyl-1,9-bis(oxane-2-carbonyl)-3H-phenoxazin-3-one;Actinomycin D;464,5;4-C04;4;ICCB Known Bioactives Library;50-76-0;GR300;5mg/mL;Inhibitors:  transcription inhibitor;DMSO;2840
;CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCC1=CC=C(O)C(OC)=C1;(5Z,8Z,11Z,14Z)-N-[(4-hydroxy-3-methoxyphenyl)methyl]icosa-5,8,11,14-tetraenamide;Arvanil;439,6;4-C05;4;ICCB Known Bioactives Library;128007-31-8;VR101;5mg/mL;Ion channel ligands:  Vaniloid receptor agonist;DMSO;2840
;Cl.COC1=CC2=NC=NC(NC3=CC(Cl)=CC=C3)=C2C=C1OC;N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine hydrochloride;AG1478;352,2;4-C06;4;ICCB Known Bioactives Library;153436-53-4;EI277;5mg/mL;Kinase inhibitors:  Tyrosine kinase inhibitor. Broad spectrum;DMSO;2840
;NC(=S)C(=C\C1=CC(O)=C(O)C=C1)\C#N;(2E)-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enethioamide;AG213 (Tyrphostin 47);220,2;4-C07;4;ICCB Known Bioactives Library;122520-86-9;EI188;5mg/mL;Kinase inhibitors:  EGF-R tyrosine kinase inhibitor;DMSO;2840
;NC(\C(=C\C1=CC2=C(NC=C2)C=C1)C#N)=C(C#N)C#N;(3Z)-2-amino-3-(1H-indol-5-ylmethylidene)prop-1-ene-1,1,3-tricarbonitrile;AG-370;259,3;4-C08;4;ICCB Known Bioactives Library;134036-53-6;EI229;5mg/mL;Kinase inhibitors:  PDGF receptor kinase inhibitor;DMSO;2840
;OC1=C(O)C=C(\C=C(/C#N)C(=O)NCC2=CC=CC=C2)C=C1;(2E)-N-benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide;AG-490;294,3;4-C09;4;ICCB Known Bioactives Library;133550-30-8;EI272;5mg/mL;Kinase inhibitors:  JAK2 inhibitor;DMSO;2840
;CC(C)(C)C1=CC(\C=C(/C#N)C(N)=S)=CC(=C1O)C(C)(C)C;(2E)-2-cyano-3-(3,5-di-tert-butyl-4-hydroxyphenyl)prop-2-enethioamide;AG-879;316,5;4-C10;4;ICCB Known Bioactives Library;148741-30-4;EI258;5mg/mL;Kinase inhibitors:  NGF receptor inhibitor;DMSO;2840
;CC(C)C[C@H](NC(=O)CNC(=O)C(C)(C)NC(=O)[C@@H](NC(=O)C(C)(C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)C(C)(C)NC(=O)[C@H](C)NC(=O)C(C)(C)NC(=O)[C@@H]1CCCN1C(=O)C(C)(C)NC(C)=O)C(C)C)C(=O)NC(C)(C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NC(C)(C)C(=O)NC(C)(C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](CO)CC1=CC=CC=C1;(4S)-4-{[(1S)-3-carbamoyl-1-{[(2S)-1-hydroxy-3-phenylpropan-2-yl]carbamoyl}propyl]carbamoyl}-4-(2-{2-[(2S)-2-{[(2S)-1-{2-[(2S)-2-(2-{2-[(2S)-2-{2-[(2S)-4-carbamoyl-2-[(2S)-2-{2-[(2S)-2-(2-{[(2S)-1-(2-acetamido-2-methylpropanoyl)pyrrolidin-2-yl]formamido}-2-methylpropanamido)propanamido]-2-methylpropanamido}propanamido]butanamido]-2-methylpropanamido}-3-methylbutanamido]-2-methylpropanamido}acetamido)-4-methylpentanamido]-2-methylpropanoyl}pyrrolidin-2-yl]formamido}-3-methylbutanamido]-2-methylpropanamido}-2-methylpropanamido)butanoic acid;Alamethicin;1964,3;4-C11;4;ICCB Known Bioactives Library;27061-78-5;A150;5mg/mL;Inhibitors:  monovalent cation ionophore;DMSO;2840
;COC1=C(OC)C=C2N=C(C=NC2=C1)C1=CC=CC=C1;6,7-dimethoxy-2-phenylquinoxaline;AG-1296;266,3;4-D02;4;ICCB Known Bioactives Library;146535-11-7;EI303;5mg/mL;Kinase inhibitors:  c-kit, FGF and PDGF kinase inhibitor;DMSO;2840
;CC1=C(C=C([N+]#[C-])C(=O)N1)C1=CC=NC=C1;3-isocyano-6-methyl-5-(pyridin-4-yl)-1,2-dihydropyridin-2-one;Milrinone;211,2;4-D03;4;ICCB Known Bioactives Library;78415-72-2;PD152;10mM;Inhibitors:  phosphodiesterase (PDE3) inhibitor;DMSO;2840
;OCC1(CO)N2CCC(CC2)C1=O;2,2-bis(hydroxymethyl)-1-azabicyclo[2.2.2]octan-3-one;PRIMA-1;185,2;4-D04;4;ICCB Known Bioactives Library;5608-24-2;GR333;5mg/mL;Inhibitors:  p53 reactivator;DMSO;2840
;CC[C@@H]1[C@H](C)C[C@@H]2[C@H]3C[C@H]4CCC(=O)C5=C(O)[C@H](CCCNC(=O)\C=C/C[C@@H]4[C@H]3C=C[C@@H]12)NC5=O;(5R,7R,8R,10R,11R,12S,15R,16S,18Z,25S)-11-ethyl-28-hydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁷,¹⁵.0⁸,¹²]octacosa-1(28),13,18-triene-2,20,27-trione;Ikarugamycin;480,6;4-D05;4;ICCB Known Bioactives Library;36531-78-9;EI313;5mg/mL;Inhibitors:  inhibits clathrin coated pit mediated endocytosis;DMSO;2840
;NC1=CC=C2C(=O)NC(=O)C3=C2C1=CC=C3;8-amino-3-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione;4-Amino-1,8-naphthalimide;212,2;4-D06;4;ICCB Known Bioactives Library;1742-95-6;AP101;5mg/mL;Inhibitors:  PARP inhibitor;DMSO;2840
;NC(=O)C1=CC=CC(N)=C1;3-aminobenzamide;3-aminobenzamide (3-ABA);136,2;4-D07;4;ICCB Known Bioactives Library;3544-24-9;G400;5mg/mL;Inhibitors:  ADP ribose polymerase, apoptosis inhibitor;DMSO;2840
;CO[C@H]1C[C@H](C)CC2=C(NCC=C)C(=O)C=C(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O;(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-[(prop-2-en-1-yl)amino]-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate;17-Allylamino-geldanamycin;585,7;4-D08;4;ICCB Known Bioactives Library;75747-14-7;EI308;5mg/mL;Inhibitors:  HSP-90 inhibitor;DMSO;2840
;COC1=CC=C(C[C@@H]2NC[C@@H](O)[C@@H]2OC(C)=O)C=C1;(2S,3R,4R)-4-hydroxy-2-[(4-methoxyphenyl)methyl]pyrrolidin-3-yl acetate;Anisomycin;265,3;4-D09;4;ICCB Known Bioactives Library;22862-76-6;ST102;10mM;Inhibitors:  MAP kinase activator;DMSO;2840
;[H][C@]12C[C@]3([H])C[C@]1(CC[C@]3(O)CO)[C@@]1(C)CC[C@@H](O)[C@@](C)(CO)[C@]1([H])CC2;(1S,2S,5R,6R,7R,10S,12R,13R)-12-hydrogenio-6,13-bis(hydroxymethyl)-2,6-dimethyltetracyclo[10.3.1.0¹,¹⁰.0²,⁷]hexadecane-5,13-diol;Aphidicolin;338,5;4-D10;4;ICCB Known Bioactives Library;38966-21-1;CC101;5mg/mL;Inhibitors:  DNA polymerase inhibitor;DMSO;2840
;COC1=CC=CC2=C1C=C(C1=C2C2=C(OCO2)C=C1C(O)=O)[N+]([O-])=O;6-methoxy-9-nitro-14,16-dioxatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-1(10),2(7),3,5,8,11,13(17)-heptaene-11-carboxylic acid;Aristolochic acid;341,3;4-D11;4;ICCB Known Bioactives Library;313-67-7;EI175;2mg/mL;Lipid biosynthesis:  phospholipase A2 inhibitor;DMSO;2840
;COCC1=NC2=C(N1)C(=O)N(C)C(=O)N2CC(C)C;8-(methoxymethyl)-1-methyl-3-(2-methylpropyl)-2,3,6,7-tetrahydro-1H-purine-2,6-dione;8-methoxymethyl-IBMX;266,3;4-E02;4;ICCB Known Bioactives Library;78033-08-6;PD150;5mg/mL;Inhibitors:  phosphodiesterase (PDE1) inhibitor;DMSO;2840
;ClC1=CC=C2N=CN=C(NCC3=CC=C4OCOC4=C3)C2=C1;N-(2H-1,3-benzodioxol-5-ylmethyl)-6-chloroquinazolin-4-amine;MBCQ;313,7;4-E03;4;ICCB Known Bioactives Library;150450-53-6;PD149;5mg/mL;Inhibitors:  phosphodiesterase (PDE5) inhibitor;DMSO;2840
;CSCC[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC[C@@H](NC[C@@H](N)CS)C(C)C)C(O)=O;(2S)-2-[(2S)-2-{[(2S)-2-{[(2R)-2-amino-3-sulfanylpropyl]amino}-3-methylbutyl]amino}-3-phenylpropanamido]-4-(methylsulfanyl)butanoic acid;B581;470,7;4-E04;4;ICCB Known Bioactives Library;149759-96-6;G235;5mg/mL;Inhibitors:  farnesyltransferase inhibitor;DMSO;2840
;CC(C)(C1=CC=C(OCC2CO2)C=C1)C1=CC=C(OCC2CO2)C=C1;2-(4-{2-[4-(oxiran-2-ylmethoxy)phenyl]propan-2-yl}phenoxymethyl)oxirane;BADGE;340,4;4-E05;4;ICCB Known Bioactives Library;1675-54-3;GR244;5mg/mL;Nuclear receptor ligands:  PPAR gamma antagonist;DMSO;2840
;[H][C@@]1(OC(=O)\C(OC)=C\C(\C)=C\[C@@H](C)[C@@H](O)[C@@H](C)C\C(C)=C\C=C\[C@@H]1OC)[C@@H](C)[C@@H](O)[C@H](C)[C@@]1(O)C[C@@H](O)[C@H](C)[C@H](O1)C(C)C;(3Z,5E,7R,8S,9S,11E,13E,15S,16R)-16-[(2S,3R,4S)-4-[(2R,4R,5S,6R)-2,4-dihydroxy-5-methyl-6-(propan-2-yl)oxan-2-yl]-3-hydroxypentan-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one;Bafilomycin A1;622,8;4-E06;4;ICCB Known Bioactives Library;88899-55-2;CM110;0.5mg/mL;Inhibitors:  vaculolar ATPase inhibitor;DMSO;2840
;CC(=O)OCOC(=O)CN(CC(=O)OCOC(C)=O)C1=C(OCCOC2=C(C=CC=C2)N(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)C=CC=C1;(acetyloxy)methyl 2-({2-[(acetyloxy)methoxy]-2-oxoethyl}[2-(2-{2-[bis({2-[(acetyloxy)methoxy]-2-oxoethyl})amino]phenoxy}ethoxy)phenyl]amino)acetate;BAPTA-AM;764,7;4-E07;4;ICCB Known Bioactives Library;139890-68-9;CA411;5mg/mL;Inhibitors:  cell permeable Ca++ chelator;DMSO;2840
;CC1=CC=C2N=C3N(CCC3(O)C(=O)C2=C1)C1=CC=CC=C1;3a-hydroxy-6-methyl-1-phenyl-1H,2H,3H,3aH,4H-pyrrolo[2,3-b]quinolin-4-one;Blebbistatin;292,3;4-E08;4;ICCB Known Bioactives Library;674289-55-5;EI315;5mg/mL;Inhibitors:  Myosin II inhibitor;DMSO;2840
;COC(C\C=C\C=C\CC\C=C/CC(C)\C=C/C(/CC(O)=O)=C\C(O)=O)C(\C)=C/C=C(\C)C(O)=O;(2E,4Z,8E,10E,14Z,18Z,20Z)-20-(carboxymethyl)-6-methoxy-2,5,17-trimethyldocosa-2,4,8,10,14,18,20-heptaenedioic acid;Bongkrekic acid;486,6;4-E09;4;ICCB Known Bioactives Library;11076-19-0;CM113;0.5mg/mL;Inhibitors:  ANT inhibitor;DMSO;2840
;CNC(=O)[C@H]1O[C@H](C(O)C1O)N1C=NC2=C1N=CN=C2NCC1=CC(I)=CC=C1;(2S,5R)-3,4-dihydroxy-5-(6-{[(3-iodophenyl)methyl]amino}-9H-purin-9-yl)-N-methyloxolane-2-carboxamide;IB-MECA;510,3;4-E10;4;ICCB Known Bioactives Library;152918-18-8;AC582 ;5mg/mL;CNS receptor ligands:  Adenosine receptor agonist;DMSO;2840
;[H][C@]1(C)CCC\C=C\C2C[C@H](O)C[C@H]2[C@H](O)\C=C\C(=O)O1;(1R,6S,13S,14aR)-1,13-dihydroxy-6-methyl-1H,4H,6H,7H,8H,9H,11aH,12H,13H,14H,14aH-cyclopenta[f]oxacyclotridecan-4-one;Brefeldin A;280,4;4-E11;4;ICCB Known Bioactives Library;20350-15-6;G405;5mg/mL;Inhibitors:  ARF GEF inhibitor;DMSO;2840
;[O-][N+](=O)C1=C2NN=C(Br)C2=CC=C1;3-bromo-7-nitro-1H-indazole;Bromo-7-nitroindazole;242,0;4-F02;4;ICCB Known Bioactives Library;74209-34-0;CN252;5mg/mL;Inhibitors:  NO synthase inhibitor;DMSO;2840
;NC1=C2N=C(Br)N(C3O[C@H]4COP(O)(=O)O[C@@H]4[C@@H]3O)C2=NC=N1;(4aS,7S,7aR)-6-(6-amino-8-bromo-9H-purin-9-yl)-2,7-dihydroxy-hexahydro-1,3,5,2λ⁵-furo[3,2-d][1,3,2λ⁵]dioxaphosphinin-2-one;8-Bromo-cAMP;408,1;4-F03;4;ICCB Known Bioactives Library;76939-46-3;CN115;5mg/mL;Activators:  PKA activator;DMSO;2840
;NC1=NC2C(N=C(Br)N2C2O[C@H]3COP(O)(=O)O[C@@H]3[C@@H]2O)C(=O)N1;9-[(4aS,7S,7aR)-2,7-dihydroxy-2-oxo-hexahydro-1,3,5,2λ⁵-furo[3,2-d][1,3,2λ⁵]dioxaphosphinin-6-yl]-2-amino-8-bromo-4,5,6,9-tetrahydro-1H-purin-6-one;8-Bromo-cGMP;426,1;4-F04;4;ICCB Known Bioactives Library;51116-01-9;CN205;5mg/mL;Activators:  PKG activator;DMSO;2840
;CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O;3-(butylamino)-4-phenoxy-5-sulfamoylbenzoic acid;Bumetanide;364,4;4-F05;4;ICCB Known Bioactives Library;28395-03-1;EI168;10mM;Inhibitors:  Na+K+Cl- cotransport inhibitor;DMSO;2840
;CCNC(=O)[C@H]1O[C@H](C(O)C1O)N1C=NC2=C1N=CN=C2N;(2S,5R)-5-(6-amino-9H-purin-9-yl)-N-ethyl-3,4-dihydroxyoxolane-2-carboxamide;5'-N-Ethylcarboxamidoadenosine (NECA);308,3;4-F06;4;ICCB Known Bioactives Library;78647-50-4;AC601;10mM;CNS receptor ligands:  adenosine receptor agonist;DMSO;2840
;CC(\C=C\C1=CC=CC(OC2=CC=C(F)C=C2)=C1)N(O)C(N)=O;1-[(3E)-4-[3-(4-fluorophenoxy)phenyl]but-3-en-2-yl]-1-hydroxyurea;BW-B 70C;316,3;4-F07;4;ICCB Known Bioactives Library;134470-38-5;EI304;5mg/mL;Lipid biosynthesis:  5 lipoxygenase inhibitor;DMSO;2840
;CCCNC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](C(C)CC)C(=O)N1CCC[C@H]1C(=O)OC;methyl (2S)-1-[(2S)-3-methyl-2-{[(2S,3S)-3-(propylcarbamoyl)oxiran-2-yl]formamido}pentanoyl]pyrrolidine-2-carboxylate;CA-074-Me;397,5;4-F08;4;ICCB Known Bioactives Library;147859-80-1;PI126;10mM;Protease inhibitors:  Cathepsin B inhibitor;DMSO;2840
;OC1=CC=C(NC2=C(C(=O)NC2=O)C2=C(C=CC=C2)[N+]([O-])=O)C=C1Cl;3-[(3-chloro-4-hydroxyphenyl)amino]-4-(2-nitrophenyl)-2,5-dihydro-1H-pyrrole-2,5-dione;SB-415286;359,7;4-F09;4;ICCB Known Bioactives Library;264218-23-7;EI311;5mg/mL;Kinase inhibitors:  GSK3 beta inhibitor;DMSO;2840
;[H]C(=O)[C@H](CCCC)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1;benzyl N-[(1S)-3-methyl-1-{[(2S)-1-oxohexan-2-yl]carbamoyl}butyl]carbamate;Calpeptin;362,5;4-F10;4;ICCB Known Bioactives Library;117591-20-5;PI101;10mM;Protease inhibitors:  Calpain inhibitor;DMSO;2840
;COC1=CC(O)=C2C(=O)C(OC)=C(C[C@@H](C)OC(=O)OC3=CC=C(O)C=C3)C3=C4C(C[C@@H](C)OC(=O)C5=CC=CC=C5)=C(OC)C(=O)C5=C(O)C=C(OC)C(C1=C23)=C45;(2R)-1-{4,9-dihydroxy-12-[(2R)-2-[(4-hydroxyphenoxycarbonyl)oxy]propyl]-2,6,7,11-tetramethoxy-3,10-dioxo-3,10-dihydroperylen-1-yl}propan-2-yl benzoate;Calphostin C;790,8;4-F11;4;ICCB Known Bioactives Library;121263-19-2;EI198;0.5mg/mL;Kinase inhibitors:  PKC inhibitor;DMSO;2840
;;;Blank;;4-G02;4;ICCB Known Bioactives Library;;;;;;2840
;CC[C@@]1(O)C(=O)OCC2=C1C=C1CC3=NC4=CC=CC=C4C=C3N1C2=O;(16S)-16-ethyl-16-hydroxy-18-oxa-1,10-diazapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-2,4,6,8,10,13,15(20)-heptaene-17,21-dione;Camptothecin;348,4;4-G03;4;ICCB Known Bioactives Library;7689-03-4;GR301;5mg/mL;Inhibitors:  Topoisomerase 1 inhibitor;DMSO;2840
;CC12C3CCC(O3)C1(C)C(=O)OC2=O;2,6-dimethyl-4,10-dioxatricyclo[5.2.1.0²,⁶]decane-3,5-dione;Cantharidin;196,2;4-G04;4;ICCB Known Bioactives Library;56-25-7;PR105;5mg/mL;Inhibitors:  PP2A inhibitor;DMSO;2840
;COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1;(6E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide;E-Capsaicin;305,4;4-G05;4;ICCB Known Bioactives Library;404-86-4;EI125;10mM;Ion channel ligands:  vanilloid receptor agonist;DMSO;2840
;OC1=C(O)C=C2CN(CCCC2=C1)C(=S)NCCC1=CC=C(Cl)C=C1;N-[2-(4-chlorophenyl)ethyl]-7,8-dihydroxy-2,3,4,5-tetrahydro-1H-2-benzazepine-2-carbothioamide;Capsazepine;376,9;4-G06;4;ICCB Known Bioactives Library;138977-28-3;NK101;5mg/mL;Ion channel ligands:  vanilloid receptor antagonist;DMSO;2840
;[H][C@]12[C@@H](O)CCN1C[C@H](O)[C@@H](O)[C@@H]2O;(1S,6S,7R,8R,8aR)-octahydroindolizine-1,6,7,8-tetrol;Castanospermine;189,2;4-G07;4;ICCB Known Bioactives Library;79831-76-8;S107;2mg/mL;Inhibitors:  glucosidase inhibitor;DMSO;2840
;OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO;2-({6-[bis(2-hydroxyethyl)amino]-4,8-bis(piperidin-1-yl)pyrimido[5,4-d][1,3]diazin-2-yl}(2-hydroxyethyl)amino)ethan-1-ol;Dipyridamole;504,6;4-G08;4;ICCB Known Bioactives Library;58-32-2;EI127;5mg/mL;Inhibitors:  cGMP phosphodiesterase inhibitor;DMSO;2840
;ClC1=CC=C2NC(=O)CSC(C2=C1)C1=C(Cl)C=CC=C1;7-chloro-5-(2-chlorophenyl)-1,2,3,5-tetrahydro-4,1-benzothiazepin-2-one;CGP-37157;324,2;4-G09;4;ICCB Known Bioactives Library;75450-34-9;CM119;5mg/mL;Inhibitors:  inhibitor of mitochondrial Na+Ca+2 exchange;DMSO;2840
;COC1=CC=C2C(C=[N+](C)C3=C2C=CC2=C3C=C3OCOC3=C2)=C1OC;17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2(10),3,8,11,14,16,18,20-nonaen-21-ium;Chelerythrine;348,4;4-G10;4;ICCB Known Bioactives Library;3895-92-9;EI225;5mg/mL;Kinase inhibitors:  PKC inhibitor;DMSO;2840
;OC1=C(O)C=C(\C=C\C(=O)OCCC2=CC=CC=C2)C=C1;2-phenylethyl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate;CAPE;284,3;4-G11;4;ICCB Known Bioactives Library;104594-70-9;FR102;10mM;Inhibitors:  Antioxidant/ NFkappa B inhibitor;DMSO;2840
;CC(C)NCC(O)C1=CC=C(N)C(=C1)C#N;2-amino-5-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzonitrile;Cimaterol;219,3;4-H02;4;ICCB Known Bioactives Library;54239-37-1;AC183;5mg/mL;CNS receptor ligands:  adrenoceptor agonist (beta);DMSO;2840
;CC(C)C[C@@H](C=O)NC(=O)[C@H](CCC(=O)OC)NC(=O)CNC(=O)C1=CC=C(C=C1)C=CC(=O)OC;methyl (4S)-4-[[2-[[4-(3-methoxy-3-oxoprop-1-enyl)benzoyl]amino]acetyl]amino]-5-[[(2S)-4-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoate;CinnGEL 2Me;503,6;4-H03;4;ICCB Known Bioactives Library;;PR115;5mg/mL;Inhibitors:  PTP1B inhibitor;DMSO;2840
;C(OC1=CC=CC=C1C1CC1)C1=NCCN1;2-(2-cyclopropylphenoxymethyl)-4,5-dihydro-1H-imidazole;Cirazoline;216,3;4-H04;4;ICCB Known Bioactives Library;40600-13-3;AC136;10mM;CNS receptor ligands:  adrenoreceptor agonist (alpha);DMSO;2840
;ClC1=CC=CC(Cl)=C1N=C1NCCN1;(2Z)-N-(2,6-dichlorophenyl)imidazolidin-2-imine;Clonidine;230,1;4-H05;4;ICCB Known Bioactives Library;4205-91-8;AC152;5mg/mL;CNS receptor ligands:  adrenoreceptor agonist (alpha);DMSO;2840
;CN1CCN(CC1)C1=NC2=C(NC3=C1C=CC=C3)C=CC(Cl)=C2;6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3(8),4,6,9,12,14-heptaene;Clozapine;326,8;4-H06;4;ICCB Known Bioactives Library;5786-21-0;D107;10mM;CNS receptor ligands:  Dopamine antagonist;DMSO;2840
;COC1=CC=C(C=CC(=O)CC(=O)C=CC2=C(OC)C(O)=CC=C2)C=C1O;1-(3-hydroxy-2-methoxyphenyl)-7-(3-hydroxy-4-methoxyphenyl)hepta-1,6-diene-3,5-dione;Curcumin;368,4;4-H07;4;ICCB Known Bioactives Library;458-37-7;EI135;10mM;Inhibitors:  NFkappaB inhibitor;DMSO;2840
;C[C@H]1C[C@H](C)C(=O)C(C1)[C@H](O)CC1CC(=O)NC(=O)C1;4-[(2R)-2-[(3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione;Cycloheximide;281,3;4-H08;4;ICCB Known Bioactives Library;66-81-9;GR310;5mg/mL;Inhibitors:  protein synthesis inhibitor ;DMSO;2840
;[H][C@@]1([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)C(C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC1=O)C(C)C;(3S,6S,9S,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecone;Cyclosporin A;1202,6;4-H09;4;ICCB Known Bioactives Library;59865-13-3;A195;10mM;Inhibitors:  calcineurin inhibitor;DMSO;2840
;CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=CC(OC2=CC=CC=C2)=C1;cyano(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate;Cypermethrin;416,3;4-H10;4;ICCB Known Bioactives Library;52315-07-8;PR100;5mg/mL;Inhibitors:  calcineurin inhibitor;DMSO;2840
;[H][C@]12[C@H](CC3=CC=CC=C3)NC(=O)[C@]11OC(=O)\C=C\[C@H](O)CCC[C@@H](C)C\C=C\[C@@]1([H])[C@H](O)C(=C)[C@H]2C;(5R,9R,13S,15S,15aS,16S,18aS,18bS)-16-benzyl-5,13-dihydroxy-9,15-dimethyl-14-methylidene-2H,5H,6H,7H,8H,9H,10H,13H,14H,15H,15aH,16H,17H,18H,18bH-oxacyclotetradeca[3,2-e]isoindole-2,18-dione;Cytochalasin B;479,6;4-H11;4;ICCB Known Bioactives Library;14930-96-2;T108;2mg/mL;Inhibitors:  F actin capper;DMSO;2840
;[H][C@]12[C@H](CC3=CC=CC=C3)NC(=O)C11[C@H](OC(C)=O)\C=C\[C@](C)(O)C(=O)[C@@H](C)C\C=C\[C@@]1([H])[C@H](O)C(=C)[C@H]2C;(3S,4S,6S,6aR,10S,12S,15R,15bR)-3-benzyl-6,12-dihydroxy-4,10,12-trimethyl-5-methylidene-1,11-dioxo-1H,2H,3H,4H,5H,6H,6aH,9H,10H,11H,12H,15H,15bH-cycloundeca[e]isoindol-15-yl acetate;Cytochalasin D;507,6;5-A02;5;ICCB Known Bioactives Library;22144-77-0;T109;5mg/mL;Inhibitors:  F actin capper;DMSO;2840
;[K+].[S-]C(=S)OC1CC2CC1C1CCCC21;potassium ({tricyclo[5.2.1.0²,⁶]decan-8-yloxy}methanethioyl)sulfanide;D609;266,5;5-A03;5;ICCB Known Bioactives Library;83373-60-8;ST330;5mg/mL;Lipid biosynthesis:  PC-PLC inhibitor;DMSO;2840
;[H]C(=O)C1=C(OC)C2=C(C=C1O)C(=O)C1=CC=CC=C1C2=O;3-hydroxy-1-methoxy-9,10-dioxo-9,10-dihydroanthracene-2-carbaldehyde;Damnacanthal;282,2;5-A04;5;ICCB Known Bioactives Library;477-84-9;EI274;5mg/mL;Kinase inhibitors:  p56lck inhibitor;DMSO;2840
;OCC1=CC=C(O1)C1=NN(CC2=CC=CC=C2)C2=C1C=CC=C2;[5-(1-benzyl-1H-indazol-3-yl)furan-2-yl]methanol;YC-1;304,3;5-A05;5;ICCB Known Bioactives Library;170632-47-0;CN223;5mg/mL;Activators:  GC stimulator /  Hif-1 alpha inhibitor ;DMSO;2840
;NC1=NC=NC2=C1N=CN2[C@]1(CO)OC(=C)[C@@H](O)[C@H]1O;(2R,3R,4S)-2-(6-amino-9H-purin-9-yl)-2-(hydroxymethyl)-5-methylideneoxolane-3,4-diol;Decoyinine;279,3;5-A06;5;ICCB Known Bioactives Library;2004-04-8;A230;5mg/mL;Inhibitors:  lowers GTP levels;DMSO;2840
;Cl.OC[C@H]1NC[C@@H](O)[C@@H](O)[C@@H]1O;(2R,3R,4R,5R)-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochloride;1-Deoxymannojirimycin hydrochloride;199,6;5-A07;5;ICCB Known Bioactives Library;84444-90-6;S109;5mg/mL;Inhibitors:  mannosidase inhibitor;DMSO;2840
;OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O;(2R,3R,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol;1-Deoxynojirimycin;163,2;5-A08;5;ICCB Known Bioactives Library;19130-96-2;S110;5mg/mL;Inhibitors:  glucosidase inhibitor;DMSO;2840
;[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C;(1R,2S,10S,11S,13R,14R,15S,17S)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-3,6-dien-5-one;Dexamethasone;392,5;5-A09;5;ICCB Known Bioactives Library;50-02-2;EI126;5mg/mL;Nuclear receptor ligands:  corticosteroid;DMSO;2840
;[Na+].CCCC(=O)NC1=C2N=CN([C@@H]3O[C@@H]4COP([O-])(=O)O[C@H]4[C@H]3OC(=O)CCC)C2=NC=N1;sodium (4aR,6R,7R,7aR)-6-(6-butanamido-9H-purin-9-yl)-7-(butanoyloxy)-2-oxo-hexahydro-1,3,5,2λ⁵-furo[3,2-d][1,3,2λ⁵]dioxaphosphinin-2-olate;Dibutyrylcyclic AMP;491,4;5-A10;5;ICCB Known Bioactives Library;16980-89-5;CN125;5mg/mL;Activators:  PKA activator;DMSO;2840
;CCCC(=O)NC1=NC2=C(N=CN2C2O[C@H]3COP(O)(=O)O[C@@H]3[C@@H]2OC(=O)CCC)C(=O)N1;(4aS,7S,7aS)-6-(2-butanamido-6-oxo-6,9-dihydro-1H-purin-9-yl)-2-hydroxy-2-oxo-hexahydro-1,3,5,2λ⁵-furo[3,2-d][1,3,2λ⁵]dioxaphosphinin-7-yl butanoate;Dibutyrylcyclic GMP;485,4;5-A11;5;ICCB Known Bioactives Library;51116-00-8;CN215;5mg/mL;Activators:  PKA activator;DMSO;2840
;[O-][N+](=O)C1=CC(C(=O)NC2=CC=CC=C2)=C(Cl)C=C1;2-chloro-5-nitro-N-phenylbenzamide;GW-9662;276,7;5-B02;5;ICCB Known Bioactives Library;22978-25-2;GR234;10mM;Nuclear receptor ligands:  PPAR gamma antagonist;DMSO;2840
;NC1CCC2=CC(O)=C(O)C=C2C1;6-amino-5,6,7,8-tetrahydronaphthalene-2,3-diol;6,7-ADTN ;179,2;5-B03;5;ICCB Known Bioactives Library;73304-33-3;D100;5mg/mL;CNS receptor ligands:  Dopamine agonist;DMSO;2840
;CC(C)C1=CC=CC(=O)C(O)=C1;2-hydroxy-4-(propan-2-yl)cyclohepta-2,4,6-trien-1-one;Hinokitiol;164,2;5-B04;5;ICCB Known Bioactives Library;499-44-5;FR110;10mM;Inhibitors:  Iron chelator;DMSO;2840
;[I+]1C2=CC=CC=C2C2=C1C=CC=C2;8λ³-iodatricyclo[7.4.0.0²,⁷]trideca-1(9),2,4,6,10,12-hexaen-8-ylium;Diphenyleneiodonium ;279,1;5-B05;5;ICCB Known Bioactives Library;10182-84-0;CN240;5mg/mL;Inhibitors:  flavoprotein inhibitor;DMSO;2840
;;;Blank;;5-B06;5;ICCB Known Bioactives Library;;;;;;2840
;Cl.COC1=CC=CC2=C1C(=O)C1=C(C(O)=C3C[C@](O)(C[C@H](O[C@H]4C[C@H](N)[C@H](O)[C@H](C)O4)C3=C1O)C(=O)CO)C2=O;(8S,10S)-10-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione hydrochloride;Doxorubicin;580,0;5-B07;5;ICCB Known Bioactives Library;25316-40-9;GR319;5mg/mL;Inhibitors:  topoisomerase II inhibitor, induces apoptosis;DMSO;2840
;OC[C@H]1O[C@H](C(O)[C@H]1O)N1C=NC2=C1C=C(Cl)C(Cl)=C2;(2R,4R,5R)-2-(5,6-dichloro-1H-1,3-benzodiazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol;DRB (Benzimidazole);319,1;5-B08;5;ICCB Known Bioactives Library;53-85-0;EI231;5mg/mL;Kinase inhibitors:  CKII inhibitor;DMSO;2840
;C1=CC(=CC=C1C2=C3C=CC(=C(C4=NC(=C(C5=CC=C([N-]5)C(=C6C=CC2=N6)C7=CC=C(C=C7)C(=O)O)C8=CC=C(C=C8)C(=O)O)C=C4)C9=CC=C(C=C9)C(=O)O)[N-]3)C(=O)O.[Cl-].[Mn+3];"manganese(3+);4-[10,15,20-tris(4-carboxyphenyl)porphyrin-22,24-diid-5-yl]benzoic acid;chloride";MnTBAP chloride;879,1;5-B09;5;ICCB Known Bioactives Library;;FR107;5mg/mL;Inhibitors:  SOD mimetic;DMSO;2840
;[H][C@@]12CC3=CC=C(OC4=CC(C[C@@]5([H])N(C)CCC6=C5C(OC5=C(OC)C=C(CCN1C)C2=C5)=C(OC)C(OC)=C6)=CC=C4OC(=O)C1=CC=C(C=C1)[N+]([O-])=O)C=C3;(1S,14R)-20,21,25-trimethoxy-15,30-dimethyl-7,23-dioxa-15,30-diazaheptacyclo[22.6.2.2³,⁶.1⁸,¹².1¹⁴,¹⁸.0²⁷,³¹.0²²,³³]hexatriaconta-3,5,8(34),9,11,18(33),19,21,24,26,31,35-dodecaen-9-yl 4-nitrobenzoate;E6 berbamine;757,8;5-B10;5;ICCB Known Bioactives Library;73885-53-7;CA302;5mg/mL;Inhibitors:  calmodulin inhibitor;DMSO;2840
;CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C;ethyl (2S,3S)-3-{[(1S)-3-methyl-1-[(3-methylbutyl)carbamoyl]butyl]carbamoyl}oxirane-2-carboxylate;E-64-d;342,4;5-B11;5;ICCB Known Bioactives Library;88321-09-9;PI107;5mg/mL;Protease inhibitors:  calpain/cathepsin inhibitor;DMSO;2840
;[H][C@](C)(O)[C@]([H])(CCCCCC)N1C=NC2=C(N)N=CN=C12;(2R,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol;EHNA ;277,4;5-C02;5;ICCB Known Bioactives Library;51350-19-7;PD129;10mM;Inhibitors:  Phosphodiesterase (PDE2) inhibitor/adenosine deaminase inhibitor;DMSO;2840
;[H][C@@]12C[C@@H](C#N)[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C;(1S,2R,5S,10S,11S,13R,14S,15S)-14-acetyl-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-ene-13-carbonitrile;Pregnenolone-16α-carbonitrile;341,5;5-C03;5;ICCB Known Bioactives Library;1434-54-4;S620;5mg/mL;Nuclear receptor ligands:  PXR/SXR agonist;DMSO;2840
;[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3CC[C@@]21[H];(1S,10R,11S,14S,15S)-15-methyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-2,4,6-triene-5,14-diol;Estradiol;272,4;5-C04;5;ICCB Known Bioactives Library;50-28-2;BL093;5mg/mL;Nuclear receptor ligands:  estrogen;DMSO;2840
;[H]C1(C)OCC2OC(O[C@H]3[C@H]4COC(=O)[C@@H]4[C@H](C4=CC(OC)=C(O)C(OC)=C4)C4=CC5=C(OCO5)C=C34)C(O)C(O)C2O1;(10R,11R,15R,16S)-16-({7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl}oxy)-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-12-one;Etoposide;588,6;5-C05;5;ICCB Known Bioactives Library;33419-42-0;GR307;10mM;Inhibitors:  topoisomerase II inhibitor;DMSO;2840
;FC(F)(F)OC1=CC=C(NN=C(C#N)C#N)C=C1;1-cyano-N-[4-(trifluoromethoxy)phenyl]methanecarbohydrazonoyl cyanide;FCCP;254,2;5-C06;5;ICCB Known Bioactives Library;370-86-5;CM120;5mg/mL;Inhibitors:  mitochondrial uncoupler;DMSO;2840
;[H][C@@]12[C@H](O)[C@H](OC(C)=O)[C@@]3(C)O[C@](C)(CC(=O)[C@]3(O)[C@@]1(C)[C@H](O)CCC2(C)C)C=C;(3R,4aR,5S,6S,6aS,10R,10aR,10bS)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-dodecahydro-1H-naphtho[2,1-b]pyran-5-yl acetate;Forskolin;410,5;5-C07;5;ICCB Known Bioactives Library;66575-29-9;CN100;10mM;Activators:  Adenylate cyclase activator;DMSO;2840
;CO[C@H]1C[C@H](C)CC2=C(OC)C(=O)C=C(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O;(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate;Geldanamycin;560,6;5-C08;5;ICCB Known Bioactives Library;30562-34-6;EI280;5mg/mL;Inhibitors:  HSP90 inhibitor;DMSO;2840
;CC1=CC=C(C=C1)C1=CCC2=CC(C)=CC(C)=C2C1=C;6,8-dimethyl-1-methylidene-2-(4-methylphenyl)-1,4-dihydronaphthalene;Genistein;260,4;5-C09;5;ICCB Known Bioactives Library;446-72-0;EI147;10mM;Kinase inhibitors:  Tyrosine kinase inhibitor;DMSO;2840
;CN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CN(CCCSC(N)=N)C2=C1C=CC=C2;[(3-{3-[4-(1-methyl-1H-indol-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl]-1H-indol-1-yl}propyl)sulfanyl]methanimidamide;Ro 31-8220;457,5;5-C10;5;ICCB Known Bioactives Library;138489-18-6;EI283;5mg/mL;Kinase inhibitors:  PKC inhibitor;DMSO;2840
;CNC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC(C)C)CC(=O)NO;(2R)-N-hydroxy-N'-[(1S)-2-(1H-indol-3-yl)-1-(methylcarbamoyl)ethyl]-2-(2-methylpropyl)butanediamide;GM6001;388,5;5-C11;5;ICCB Known Bioactives Library;142880-36-2;EI300;5mg/mL;Protease inhibitors:  broad spectrum MMP inhibitor ;DMSO;2840
;;;Blank;;5-D02;5;ICCB Known Bioactives Library;;;;;;2840
;CS(=O)(=O)NC1=C(OC2=CC=CC=C2)C=C(C=C1)[N+]([O-])=O;N-(4-nitro-2-phenoxyphenyl)methanesulfonamide;Nimesulide;308,3;5-D03;5;ICCB Known Bioactives Library;51803-78-2;EI287;5mg/mL;Lipid biosynthesis:  Cox 2 inhibitor;DMSO;2840
;CC1CNCCN1S(=O)(=O)C1=CC=CC2=CN=CC=C12;5-[(2-methylpiperazin-1-yl)sulfonyl]isoquinoline;H7;291,4;5-D04;5;ICCB Known Bioactives Library;84477-87-2;EI148;10mM;Kinase inhibitors:  kinase inhibitor;DMSO;2840
;BrC1=CC=C(\C=C\CNCCNS(=O)(=O)C2=CC=CC3=CN=CC=C23)C=C1;N-(2-{[(2E)-3-(4-bromophenyl)prop-2-en-1-yl]amino}ethyl)isoquinoline-5-sulfonamide;H-89;446,4;5-D05;5;ICCB Known Bioactives Library;127243-85-0;EI196;5mg/mL;Kinase inhibitors:  PKA inhibitor;DMSO;2840
;Cl.Cl.NCCNS(=O)(=O)C1=CC=CC2=CN=CC=C12;N-(2-aminoethyl)isoquinoline-5-sulfonamide dihydrochloride;H9;324,2;5-D06;5;ICCB Known Bioactives Library;116700-36-8;EI195;10mM;Kinase inhibitors:  kinase inhibitor;DMSO;2840
;Cl.Cl.O=S(=O)(N1CCCNCC1)C1=C2C=CN=CC2=CC=C1;5-(1,4-diazepane-1-sulfonyl)isoquinoline dihydrochloride;HA1077;364,3;5-D07;5;ICCB Known Bioactives Library;103745-39-7;EI233;2mg/mL;Kinase inhibitors:  inhibitor of Rho-dependent kinases;DMSO;2840
;NC(=N)NCCNS(=O)(=O)C1=CC=CC2=CN=CC=C12;1-[2-(isoquinoline-5-sulfonamido)ethyl]guanidine;HA-1004;293,3;5-D08;5;ICCB Known Bioactives Library;91742-10-8;EI184;5mg/mL;Kinase inhibitors:  kinase inhibitor;DMSO;2840
;COCC1=CC(O)=C(O)C(O)=C1C1=C(COC)C=C(O)C(O)=C1O;5-(methoxymethyl)-4-[2,3,4-trihydroxy-6-(methoxymethyl)phenyl]benzene-1,2,3-triol;HBDDE;338,3;5-D09;5;ICCB Known Bioactives Library;154675-18-0;EI273;5mg/mL;Kinase inhibitors:  PKC inhibitor;DMSO;2840
;NCCC1=CNC=N1;2-(1H-imidazol-4-yl)ethan-1-amine;Histamine;111,1;5-D10;5;ICCB Known Bioactives Library;51-74-1;AC764;5mg/mL;CNS receptor ligands:  Histamine receptor agonist;DMSO;2840
;CC(=O)OCOC(C1=CC2=C(C=CC=C2)C=C1)P(=O)(OCOC(C)=O)OCOC(C)=O;({[(acetyloxy)methoxy]({[(acetyloxy)methoxy](naphthalen-2-yl)methyl})phosphoryl}oxy)methyl acetate;HNMPA-(AM)3;454,4;5-D11;5;ICCB Known Bioactives Library;120944-03-8;EI248;5mg/mL;Kinase inhibitors:  Insulin receptor TK inhibitor;DMSO;2840
;Cl.Cl.Cl.CCOC1=CC=C(C=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CCN(C)CC1;2-[2-(4-ethoxyphenyl)-1H-1,3-benzodiazol-5-yl]-5-(4-methylpiperazin-1-yl)-1H-1,3-benzodiazole trihydrochloride;Hoechst  33342·3HCl (BisBenzimide);561,9;5-E02;5;ICCB Known Bioactives Library;23491-52-3;GR303;5mg/mL;Inhibitors:  DNA minor groove binder;DMSO;2840
;C\C=C1/C2CC3=C(C=CC(=O)N3)C1(N)CC(C)=C2;(13E)-1-amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.0²,⁷]trideca-2(7),3,10-trien-5-one;(-)-Huperzine A;242,3;5-E03;5;ICCB Known Bioactives Library;102518-79-6;C117;5mg/mL;Inhibitors:  acetylcholinesterase inhibitor;DMSO;2840
;[H][C@@]12CC[C@H]([C@H](C)CC[C@@H](O)C(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C;(1S,2R,5S,10S,11S,14R,15R)-14-[(2R,5R)-5-hydroxy-6-methylheptan-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-ol;24(S)-hydroxycholesterol;402,7;5-E04;5;ICCB Known Bioactives Library;474-73-7;GR230;5mg/mL;Nuclear receptor ligands:  LXR agonist;DMSO;2840
;C[C@@H]([C@@H](C)N1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1;4-[(2S,3R)-3-(3,5-dioxopiperazin-1-yl)butan-2-yl]piperazine-2,6-dione;ICRF-193;282,3;5-E05;5;ICCB Known Bioactives Library;21416-68-2;GR332;5mg/mL;Inhibitors:  topo II inhibitor that does not cause DNA breaks;DMSO;2840
;COC1=CC=C2N(C(=O)C3=CC=C(Cl)C=C3)C(C)=C(CC(O)=O)C2=C1;2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetic acid;Indomethacin;357,8;5-E06;5;ICCB Known Bioactives Library;53-86-1;EI131;5mg/mL;Lipid biosynthesis:  cyclooxygenase inhibitor;DMSO;2840
;[H][C@@]1(C[C@H](O)[C@H](C)[C@H](O)[C@H](C)\C=C\C[C@@H](C)C[C@@H](C)C(\O)=C\C(=O)[C@@H](C)C[C@@H](C)C[C@H](C)CCC(O)=O)CC[C@](C)(O1)[C@@]1([H])CC[C@](C)(O1)[C@@H](C)O;(4R,6S,8S,10Z,12R,14R,16E,18R,19R,20S,21S)-11,19,21-trihydroxy-22-[(2S,5S)-5-[(2R,5S)-5-[(1R)-1-hydroxyethyl]-5-methyloxolan-2-yl]-5-methyloxolan-2-yl]-4,6,8,12,14,18,20-heptamethyl-9-oxodocosa-10,16-dienoic acid;Ionomycin;709,0;5-E07;5;ICCB Known Bioactives Library;56092-81-0;CA201;5mg/mL;Ion channel ligands:  Ca++ ionophore;DMSO;2840
;CC(C)CN1C2=C(NC=N2)C(=O)N(C)C1=O;1-methyl-3-(2-methylpropyl)-2,3,6,7-tetrahydro-1H-purine-2,6-dione;IBMX;222,2;5-E08;5;ICCB Known Bioactives Library;28822-58-4;PD140;5mg/mL;Inhibitors:  PDE inhibitor (broad spec), adenosineR agonist;DMSO;2840
;OCCSC1=C(SCCO)C(=O)C2=CC=CC=C2C1=O;2,3-bis[(2-hydroxyethyl)sulfanyl]-1,4-dihydronaphthalene-1,4-dione;NSC-95397;310,4;5-E09;5;ICCB Known Bioactives Library;93718-83-3;EI309;5mg/mL;Inhibitors:  CDC25 phosphatase inhibitor;DMSO;2840
;OC1=CC=CC2=C1C(=O)C=CC2=O;5-hydroxy-1,4-dihydronaphthalene-1,4-dione;Juglone;174,2;5-E10;5;ICCB Known Bioactives Library;481-39-0;BL169;5mg/mL;Inhibitors:  PIN1 inhibitor;DMSO;2840
;[H][C@]12C[C@](O)(C(=O)OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=C(C=CC=C5)N2C4=C13;methyl (15S,16R,18R)-18-hydrogenio-16-hydroxy-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1¹⁵,¹⁸.0²,⁶.0⁷,²⁷.0⁸,¹³.0¹⁹,²⁶.0²⁰,²⁵]octacosa-1,6,8,10,12,20(25),21,23,26-nonaene-16-carboxylate;K252A;467,5;5-E11;5;ICCB Known Bioactives Library;97161-97-2;EI152;0.5mg/mL;10mM;DMSO;2840
;[H]C(CC1=CC=C(OS(=O)(=O)C2=C3C=CN=CC3=CC=C2)C=C1)(N(C)S(=O)(=O)C1=CC=CC2=CN=CC=C12)C(=O)N1CCN(CC1)C1=CC=CC=C1;4-[2-(N-methylisoquinoline-5-sulfonamido)-3-oxo-3-(4-phenylpiperazin-1-yl)propyl]phenyl isoquinoline-5-sulfonate;KN-62;721,8;5-F02;5;ICCB Known Bioactives Library;127191-97-3;EI230;5mg/mL;Kinase inhibitors:  CaM kinase II inhibitor;DMSO;2840
;[H][C@]12C[C@](O)(C(=O)OCCCCCC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=C(C=CC=C5)N2C4=C13;hexyl (15S,16R,18R)-18-hydrogenio-16-hydroxy-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1¹⁵,¹⁸.0²,⁶.0⁷,²⁷.0⁸,¹³.0¹⁹,²⁶.0²⁰,²⁵]octacosa-1,6,8,10,12,20(25),21,23,26-nonaene-16-carboxylate;KT-5720;537,6;5-F03;5;ICCB Known Bioactives Library;108068-98-0;EI199;0.5mg/mL;Kinase inhibitors:  PKA inhibitor;DMSO;2840
;Cl.Cl.CCC(C)[C@@H](CO[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS;propan-2-yl (2S)-2-[(2S)-2-{[(2S)-2-{[(2R)-2-amino-3-sulfanylpropyl]amino}-3-methylpentyl]oxy}-3-phenylpropanamido]-4-methanesulfonylbutanoate dihydrochloride;L-744,832;632,7;5-F04;5;ICCB Known Bioactives Library;1177806-11-9;G242;5mg/mL;Inhibitors:  Ras farnesyltransferase inhibitor;DMSO;2840
;[O-][N+]1=C(C#N)C(=NO1)C1=CC=CC=C1;3-cyano-4-phenyl-1,2,5-oxadiazol-2-ium-2-olate;Furoxan;187,2;5-F05;5;ICCB Known Bioactives Library;125520-62-9;CN255;5mg/mL;Activators:  NO donor;DMSO;2840
;[H][C@]1(CSC(=O)N1)[C@@]1(O)C[C@H]2C[C@@H](CC[C@H](C)\C=C/CC\C(C)=C/C(=O)O2)O1;(4R)-4-[(1R,4Z,8Z,10S,13R,15R)-15-hydroxy-5,10-dimethyl-3-oxo-2,14-dioxabicyclo[11.3.1]heptadeca-4,8-dien-15-yl]-1,3-thiazolidin-2-one;Latrunculin B;395,5;5-F06;5;ICCB Known Bioactives Library;76343-94-7;T110;5mg/mL;Inhibitors:  Actin inhibitor;DMSO;2840
;OC(=O)C1=CC(=CC=C1O)N(CC1=CC=CC=C1O)CC1=C(O)C=CC(O)=C1;5-{[(2,5-dihydroxyphenyl)methyl][(2-hydroxyphenyl)methyl]amino}-2-hydroxybenzoic acid;Lavendustin A;381,4;5-F07;5;ICCB Known Bioactives Library;125697-92-9;EI185;5mg/mL;Kinase inhibitors:  Tyrosine kinase inhibitor EGF-R);DMSO;2840
;CC(C)N1C=NC2=C(NCC3=CC=CC=C3)N=C(NCCO)N=C12;2-{[6-(benzylamino)-9-(propan-2-yl)-9H-purin-2-yl]amino}ethan-1-ol;N9-Isopropylolomoucine;326,4;5-F08;5;ICCB Known Bioactives Library;158982-15-1;CC202;5mg/mL;Kinase inhibitors:  CDC-2 kinase inhibitor;DMSO;2840
;[H]C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O;(2S)-N-[(1S)-1-{[(2S)-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl}-3-methylbutyl]-2-acetamido-4-methylpentanamide;Leupeptin;426,6;5-F09;5;ICCB Known Bioactives Library;103476-89-7;PI118;5mg/mL;Protease inhibitors:  protease inhibitor;DMSO;2840
;CC1=CC=C(C=C1)S(=O)(=O)\C=C\C#N;(2E)-3-(4-methylbenzenesulfonyl)prop-2-enenitrile;BAY 11-7082;207,2;5-F10;5;ICCB Known Bioactives Library;195462-67-7;EI278;10mM;Inhibitors:  Inhibits IKK kinase activation;DMSO;2840
;OC1=CC=C(C=C(C#N)C#N)C=C1;2-[(4-hydroxyphenyl)methylidene]propanedinitrile;Tyrphostin-8;170,2;5-F11;5;ICCB Known Bioactives Library;3785-90-8;PR113;10mM;Inhibitors:  Calcineurin inhibitor;DMSO;2840
;COC(=O)[C@@H](N)CCCN\C(N)=N\[N+]([O-])=O;methyl (2S)-2-amino-5-[(Z)-2-nitrocarbamimidamido]pentanoate;L-NAME;233,2;5-G02;5;ICCB Known Bioactives Library;51298-62-5;CN242;5mg/mL;Inhibitors:  NO synthesis inhibitor;DMSO;2840
;O=C1C=C(OC2=C(C=CC=C12)C1=CC=CC=C1)N1CCOCC1;2-(morpholin-4-yl)-8-phenyl-4H-chromen-4-one;LY-294002;307,3;5-G03;5;ICCB Known Bioactives Library;154447-36-6;ST420;10mM;Lipid biosynthesis:  PI-3-Kinase inhibitor;DMSO;2840
;O=C1C=C(NC2=CC=CC=C2)C(=O)C2=CC=CN=C12;6-(phenylamino)-5,8-dihydroquinoline-5,8-dione;LY-83583;250,3;5-G04;5;ICCB Known Bioactives Library;91300-60-6;CN200;5mg/mL;Inhibitors:  Inhibits NO-activation of guanylate cyclase ;DMSO;2840
;NC1=C2C(I)=CN([C@@H]3O[C@H](CO)C(O)C3O)C2=NC=N1;(2R,5R)-2-{4-amino-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-5-(hydroxymethyl)oxolane-3,4-diol;5-Iodotubercidin;392,1;5-G05;5;ICCB Known Bioactives Library;24386-93-4;EI293;5mg/mL;Kinase inhibitors:  ERK-2 inhibitor;DMSO;2840
;C\C(CCC1=C(C)CCCC1(C)C)=C/CCC1C=CC(OC1O)C1=CC(=O)OC1O;5-hydroxy-4-{6-hydroxy-5-[(3E)-4-methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hex-3-en-1-yl]-5,6-dihydro-2H-pyran-2-yl}-2,5-dihydrofuran-2-one;Manoalide;416,6;5-G06;5;ICCB Known Bioactives Library;75088-80-1;EI177;5mg/mL;Lipid biosynthesis:  Phospholipase A2 inhibitor;DMSO;2840
;CCCC[C@@H](C)\C=C(/C)\C=C(/C)C(=O)NC1=C[C@@](O)(\C=C\C=C\C=C\C(=O)NC2=C(O)CCC2=O)[C@@H]2O[C@@H]2C1=O;(2E,4E,6R)-N-[(1S,5S,6R)-5-hydroxy-5-[(1E,3E,5E)-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)carbamoyl]hexa-1,3,5-trien-1-yl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4,6-trimethyldeca-2,4-dienamide;Manumycin A;550,6;5-G07;5;ICCB Known Bioactives Library;52665-74-4;G236;5mg/mL;Inhibitors:  ras farnesylation inhibitor;DMSO;2840
;C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.N.N.N.N.N.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.CN.CN.CN.CN.CN.CN.CN.CN.CN.CN.CN.CN.CN.CN;isoleucylasparagylleucyllysylalanylleucylalanylalanylleucylalanyllysyllysylisoleucylleucinamide;Mastoparan;1688,6;5-G08;5;ICCB Known Bioactives Library;72093-21-1;G410;5mg/mL;Activators:  activates heterotrimeriuc GTPases;DMSO;2840
;CC1=NN(C(=O)C1)C1=CC=CC=C1;3-methyl-1-phenyl-4,5-dihydro-1H-pyrazol-5-one;MCI-186;174,2;5-G09;5;ICCB Known Bioactives Library;89-25-8;FR103;5mg/mL;Inhibitors:  antioxidant, cytoprotectant;DMSO;2840
;CN1C(=O)[C@]23CC4=CC=C[C@H](O)[C@H]4N2C(=O)[C@@]1(CO)SS3;(1R,7S,8S,11R)-7-hydroxy-11-(hydroxymethyl)-15-methyl-12,13-dithia-9,15-diazatetracyclo[9.2.2.0¹,⁹.0³,⁸]pentadeca-3,5-diene-10,14-dione;Gliotoxin;326,4;5-G10;5;ICCB Known Bioactives Library;67-99-2;PI129 ;5mg/mL;Protease inhibitors:  Inhibitor of 20S-proteasome chymotrypsin activity;DMSO;2840
;C\C(O)=C(/C#N)C(=O)NC1=CC(Br)=CC=C1Br;(2Z)-2-cyano-N-(2,5-dibromophenyl)-3-hydroxybut-2-enamide;LFM-A13;360,0;5-G11;5;ICCB Known Bioactives Library;62004-35-7;EI295;5mg/mL;Kinase inhibitors:  BTK inhibitor;DMSO;2840
;CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)NC(CCC(O)=O)C(O)=O;2-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)formamido]pentanedioic acid;Methotrexate;454,4;5-H02;5;ICCB Known Bioactives Library;59-05-2;CC103;5mg/mL;CNS receptor ligands:  DHFR inhibitor;DMSO;2840
;ClC1=NC=C(C=C1)C1CC2CCC1N2;2-(6-chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane;(±)-Epibatidine;208,7;5-H03;5;ICCB Known Bioactives Library;140111-52-0;C114;10mM;CNS receptor ligands:  nicotinic cholinergic agonist;DMSO;2840
;[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC;(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate;Mevinolin (Lovastatin);404,5;5-H04;5;ICCB Known Bioactives Library;75330-75-5;G226;5mg/mL;Lipid biosynthesis:  Inhibitor HMG-CoA reductase;DMSO;2840
;[H][C@]12CN3C4=C([C@@H](COC(N)=O)[C@@]3(OC)[C@@]1([H])N2)C(=O)C(N)=C(C)C4=O;[(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0²,⁷.0⁴,⁶]trideca-1(9),11-dien-8-yl]methyl carbamate;Mitomycin C;334,3;5-H05;5;ICCB Known Bioactives Library;50-07-7;GR311;5mg/mL;Inhibitors:  cross links DNA;DMSO;2840
;IC1=C2C=CC=C(C2=CC=C1)S(=O)(=O)N1CCCNCC1;1-[(5-iodonaphthalen-1-yl)sulfonyl]-1,4-diazepane;ML7;416,3;5-H06;5;ICCB Known Bioactives Library;109376-83-2;EI197;10mM;Kinase inhibitors:  kinase inhibitor;DMSO;2840
;ClC1=C2C=CC=C(C2=CC=C1)S(=O)(=O)N1CCCNCC1;1-[(5-chloronaphthalen-1-yl)sulfonyl]-1,4-diazepane;ML9;324,8;5-H07;5;ICCB Known Bioactives Library;105637-50-1;EI153;5mg/mL;Kinase inhibitors:  kinase inhibitor;DMSO;2840
;CCOC(=O)C1=C(C)NC(=S)NC1C1=CC(O)=CC=C1;ethyl 4-(3-hydroxyphenyl)-6-methyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate;Monastrol;292,4;5-H08;5;ICCB Known Bioactives Library;329689-23-8;GR322;5mg/mL;Inhibitors:  Eg5 inhibitor;DMSO;2840
;OC1=C(Br)C=C(\C=C2/C(=O)NC3=CC=C(I)C=C23)C=C1Br;(3Z)-3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-2,3-dihydro-1H-indol-2-one;GW-5074;520,9;5-H09;5;ICCB Known Bioactives Library;220904-83-6;EI307;5mg/mL;Kinase inhibitors:  cRAF1 kinase inhibitor;DMSO;2840
;[Na+].[H][C@@]1(C[C@H](C)[C@@]([H])(O1)[C@]1(CC)CC[C@@]([H])(O1)[C@]1(C)CC[C@]2(C[C@H](O)[C@@H](C)[C@]([H])(O2)[C@@H](C)[C@@H](OC)C(C)C([O-])=O)O1)[C@@]1([H])O[C@@](O)(CO)[C@H](C)C[C@@H]1C;sodium (3R,4S)-4-[(2S,5R,7S,8R,9S)-2-[(2R,5S)-5-ethyl-5-[(2R,3S,5R)-5-[(2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]oxolan-2-yl]-9-hydroxy-2,8-dimethyl-1,6-dioxaspiro[4.5]decan-7-yl]-3-methoxy-2-methylpentanoate;Monensin sodium;692,9;5-H10;5;ICCB Known Bioactives Library;22373-78-0;A248;5mg/mL;Ion channel ligands:  Na+ ionophore;DMSO;2840
;[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@H]1C(=O)O[C@@H]([C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@@H](O)[C@@H](C1)OC;(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-24-hydrogenio-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0⁴,⁹]octacos-18-ene-2,3,10,16-tetrone;FK-506;804,0;5-H11;5;ICCB Known Bioactives Library;104987-11-3;A235;10mM;Inhibitors:  FKBP ligand;DMSO;2840
;COC(=O)NC1=NC2=CC(=CC=C2N1)C(=O)C1=CC=CS1;methyl N-[5-(thiophene-2-carbonyl)-1H-1,3-benzodiazol-2-yl]carbamate;Nocodazole;301,3;6-A02;6;ICCB Known Bioactives Library;31430-18-9;T101;10mM;Inhibitors:  tubulin inhibitor;DMSO;2840
;CCCCCCCCCCCCCCCCCCC1=CC=C(C=C1)C(=O)\C=C\C(O)=O;(2E)-4-(4-octadecylphenyl)-4-oxobut-2-enoic acid;OBAA;428,6;6-A03;6;ICCB Known Bioactives Library;134531-42-3;ST315;5mg/mL;Inhibitors:  phospholipase A2 inhibitor;DMSO;2840
;[H][C@@]1(CC[C@@]2(CCC3O[C@H]([C@@H](O)C[C@H](C)C4O[C@@]5(CCCCO5)CC[C@H]4C)C(=C)[C@@H](O)[C@]3([H])O2)O1)\C=C\[C@@H](C)[C@@H]1CC(C)=C[C@]2(O1)O[C@]([H])(C[C@@](C)(O)C(O)=O)CC[C@H]2O;3-[(2S,5R,6R,8S)-8-[(2R,3E)-4-[(2R,5R,6'S,8'R,8'aS)-8'-hydroxy-6'-[(1S,3S)-1-hydroxy-3-[(3R,6S)-3-methyl-1,7-dioxaspiro[5.5]undecan-2-yl]butyl]-7'-methylidene-hexahydro-3'H-spiro[oxolane-2,2'-pyrano[3,2-b]pyran]-5-yl]but-3-en-2-yl]-5-hydroxy-10-methyl-1,7-dioxaspiro[5.5]undec-10-en-2-yl]-2-hydroxy-2-methylpropanoic acid;Okadaic acid;805,0;6-A04;6;ICCB Known Bioactives Library;78111-17-8;EI181;0.5mg/mL;Inhibitors:  PP1 PP2A inhibitor;DMSO;2840
;[H][C@]1(C[C@H](C)O)O[C@@]2(CC[C@H]1C)O[C@]1([H])CC[C@]([H])(CC)\C=C\C=C\C[C@H](C)[C@@H](O)[C@](C)(O)C(=O)[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)\C=C\C(=O)O[C@@]([H])([C@H]1C)[C@H]2C;(1S,4E,5'R,6R,6'R,7S,8R,10S,11S,12R,14S,15R,16S,18E,20E,22S,25R,27S,28R,29S)-22-ethyl-1,25-dihydrogenio-7,11,14,15-tetrahydroxy-6'-[(2S)-2-hydroxypropyl]-5',6,8,10,12,14,16,28,29-nonamethyl-2,26-dioxaspiro[bicyclo[23.3.1]nonacosane-27,2'-oxane]-4,18,20-triene-3,9,13-trione;Oligomycin A;791,1;6-A05;6;ICCB Known Bioactives Library;579-13-5;CM111;5mg/mL;Inhibitors:  Fo ATP synthase inhibitor ;DMSO;2840
;CN1C=NC2=C(NCC3=CC=CC=C3)N=C(NCCO)N=C12;2-{[6-(benzylamino)-9-methyl-9H-purin-2-yl]amino}ethan-1-ol;Olomoucine;298,3;6-A06;6;ICCB Known Bioactives Library;101622-51-9;CC200;5mg/mL;Kinase inhibitors:  CDK inhibitor;DMSO;2840
;[H][C@@]12CC[C@]3(O)C[C@H](C[C@@H](O)[C@]3(CO)[C@@]1([H])[C@H](O)C[C@]1(C)[C@H](CC[C@]21O)C1=CC(=O)OC1)OC1OC(C)C(O)C(O)C1O;4-[(1S,2R,3R,5S,7S,10R,11S,14R,15R,17R)-3,7,11,17-tetrahydroxy-2-(hydroxymethyl)-15-methyl-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]-2,5-dihydrofuran-2-one;Ouabain;584,7;6-A07;6;ICCB Known Bioactives Library;11018-89-6;CM109;5mg/mL;Inhibitors:  Na+K+ATPase inhibitor;DMSO;2840
;;;Blank;;6-A08;6;ICCB Known Bioactives Library;;;;;;2840
;COC1=C(N)C(=CC=C1)C1=CC(=O)C2=CC=CC=C2O1;2-(2-amino-3-methoxyphenyl)-4H-chromen-4-one;PD 98059;267,3;6-A09;6;ICCB Known Bioactives Library;167869-21-8;EI360;5mg/mL;Kinase inhibitors:  MEK inhibitor;DMSO;2840
;CN(C)C1=CC=C(\C=C2/C(=O)NC3=CC=CC=C23)C=C1;(3Z)-3-{[4-(dimethylamino)phenyl]methylidene}-2,3-dihydro-1H-indol-2-one;SU-4312;264,3;6-A10;6;ICCB Known Bioactives Library;5812-07-7;EI306;5mg/mL;Kinase inhibitors:  VEGF-R (Flk-1) tyrosine kinase ;DMSO;2840
;CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CC(C)C)C(C)C)C(C)C)[C@@H](O)CC(O)=O;(3S,4S)-3-hydroxy-4-[(2S)-2-[(3S,4S)-3-hydroxy-6-methyl-4-[(2S)-3-methyl-2-[(2S)-3-methyl-2-(3-methylbutanamido)butanamido]butanamido]heptanamido]propanamido]-6-methylheptanoic acid;Pepstatin;685,9;6-A11;6;ICCB Known Bioactives Library;26305-03-3;PI120;5mg/mL;Protease inhibitors:  protease inhibitor;DMSO;2840
;O=C1NC2=C(C=CC=C2)C2=CC=CC=C12;5,6-dihydrophenanthridin-6-one;6(5H)-Phenanthridinone;195,2;6-B02;6;ICCB Known Bioactives Library;1015-89-0;AP100;5mg/mL;Inhibitors:  PARP inhibitor;DMSO;2840
;[H][C@]12[C@]3([H])C=C(CO)C[C@]4(O)C(=O)C(C)=C[C@@]4([H])[C@@]3(O)[C@H](C)[C@@H](OC(=O)CCCCCCCCCCCCC)[C@@]1(OC(C)=O)C2(C)C;(1S,2S,6R,10S,11R,13S,14R,15R)-13-(acetyloxy)-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-14-yl tetradecanoate;Phorbol 12-myristate 13-acetate;616,8;6-B03;6;ICCB Known Bioactives Library;16561-29-8;PE160;5mg/mL;Activators:  PKC activator;DMSO;2840
;CC1=CC=C(C=C1)C(=O)CN1C(=N)SC2=C1CCCC2;2-(2-imino-2,3,4,5,6,7-hexahydro-1,3-benzothiazol-3-yl)-1-(4-methylphenyl)ethan-1-one;Pifithrin-α;286,4;6-B04;6;ICCB Known Bioactives Library;63208-82-2;GR325;5mg/mL;Inhibitors:  p53 inhibitor;DMSO;2840
;ClC1=CC=C(C=C1)C1=C(\C=N\OCC2=CC(Cl)=C(Cl)C=C2)N2C=CSC2=N1;(E)-{[6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazol-5-yl]methylidene}[(3,4-dichlorophenyl)methoxy]amine;CITCO;436,7;6-B05;6;ICCB Known Bioactives Library;338404-52-7;GR233;5mg/mL;Nuclear receptor ligands:  Const. androstane receptor (CAR) agonist;DMSO;2840
;CN1C(C(=O)NC2=NC=CC=C2)=C(O)C2=CC=CC=C2S1(=O)=O;4-hydroxy-2-methyl-1,1-dioxo-N-(pyridin-2-yl)-2H-1λ⁶,2-benzothiazine-3-carboxamide;Piroxicam;331,3;6-B06;6;ICCB Known Bioactives Library;36322-90-4;EI219;5mg/mL;Lipid biosynthesis:  COX1 inhibitor;DMSO;2840
;[H][C@@]12C[C@H](C)CN[C@@]1([H])[C@@H](C)[C@@]1(CC[C@]3([H])C(C[C@@]4([H])[C@@]3([H])CC=C3C[C@@H](O)CC[C@]43C)=C1C)O2;(3S,3'R,3'aS,6'S,6aS,6bS,7'aR,9R,11aS,11bR)-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a,11b-octadecahydro-3'H-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridine]-3-ol;Cyclopamine;411,6;6-B07;6;ICCB Known Bioactives Library;4449-51-8;GR334;5mg/mL;Inhibitors:  Hedgehog pathway inhibitor;DMSO;2840
;CC1=CC=C(C=C1)C1=NN(C2=C1C(N)=NC=N2)C(C)(C)C;1-tert-butyl-3-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine;PP1;281,4;6-B08;6;ICCB Known Bioactives Library;172889-26-8;EI275;5mg/mL;Protease inhibitors:  src family trosine kinase inhibitor;DMSO;2840
;COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1;2-[4-(furan-2-carbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine;Prazocin;383,4;6-B09;6;ICCB Known Bioactives Library;19216-56-9;AC146;10mM;CNS receptor ligands:  adrenoreceptor agonist;DMSO;2840
;[I-].[I-].CC[N+](C)(CC)CCC[N+]1=C(C2=CC=CC=C2)C2=CC(N)=CC=C2C2=C1C=C(N)C=C2;3,8-diamino-5-{3-[diethyl(methyl)azaniumyl]propyl}-6-phenylphenanthridin-5-ium diiodide;Propidium iodide;668,4;6-B10;6;ICCB Known Bioactives Library;25535-16-4;AP401;5mg/mL;Inhibitors:  DNA intercalator;DMSO;2840
;Cl.CC(C)NC[C@H](O)COC1=CC=CC2=CC=CC=C12;[(2S)-2-hydroxy-3-(naphthalen-1-yloxy)propyl](propan-2-yl)amine hydrochloride;(S)-(-)-propranolol·HCl;295,8;6-B11;6;ICCB Known Bioactives Library;4199-10-4;AR107;10mM;CNS receptor ligands:  adrenoceptor antagonist (beta);DMSO;2840
;Cl.Cl.COC1=CC=C(C[C@H](N)C(=O)N[C@@H]2[C@@H](O)O[C@H]([C@@H]2O)N2C=NC3=C(N=CN=C23)N(C)C)C=C1;(2S)-2-amino-N-[(2S,3S,4R,5R)-5-[6-(dimethylamino)-9H-purin-9-yl]-2,4-dihydroxyoxolan-3-yl]-3-(4-methoxyphenyl)propanamide dihydrochloride;Puromycin·2HCl;530,4;6-C02;6;ICCB Known Bioactives Library;58-58-2;GR312;5mg/mL;Inhibitors:  protein synthesis inhibitor;DMSO;2840
;NC(=O)C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC=CC=N1)C1=CC=C2OCOC2=C1;4-[4-(2H-1,3-benzodioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl]benzamide;SB-431542;384,4;6-C03;6;ICCB Known Bioactives Library;301836-41-9;EI314;5mg/mL;Kinase inhibitors:  ALK4, ALK5, ALK7 inhibitor;DMSO;2840
;O=C1C2=C3C(NN=C3C3=CC=CC=C13)=CC=C2;14,15-diazatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one;SP-600125;220,2;6-C04;6;ICCB Known Bioactives Library;129-56-6;EI305;5mg/mL;Kinase inhibitors:  JNK inhibitor;DMSO;2840
;[H]O[H].[H]O[H].OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1;2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one dihydrate;Quercetin·2H2O;338,3;6-C05;6;ICCB Known Bioactives Library;6151-25-3;AC1142;5mg/mL;Kinase inhibitors:  kinase inhibitor (plus other);DMSO;2840
;[H][C@@]12CC[C@@H](C)[C@@](O)(O1)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@]([H])(CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C2)OC)[C@H](C)C[C@@H]1CC[C@@H](O)[C@@H](C1)OC;(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-32-hydrogenio-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0⁴,⁹]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone;Rapamycin;914,2;6-C06;6;ICCB Known Bioactives Library;53123-88-9;A275;5mg/mL;Inhibitors:  FRAP inhibitor ;DMSO;2840
;CC(C)[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O;2-[(2R,5S,8S,11S)-5-benzyl-11-(3-carbamimidamidopropyl)-3,6,9,12,15-pentaoxo-8-(propan-2-yl)-1,4,7,10,13-pentaazacyclopentadecan-2-yl]acetic acid;Cyclo [Arg-Gly-Asp-D-Phe-Val];574,6;6-C07;6;ICCB Known Bioactives Library;137813-35-5;AM100;5mg/mL;Inhibitors:  integrin inhibitor;DMSO;2840
;O=C(NCCCCCCNC(=O)ON=C1CCCCC1)ON=C1CCCCC1;cyclohexylideneamino N-[6-({[(cyclohexylideneamino)oxy]carbonyl}amino)hexyl]carbamate;RHC-80267;394,5;6-C08;6;ICCB Known Bioactives Library;83654-05-1;ST300;5mg/mL;Lipid biosynthesis:  DAG lipase inhibitor;DMSO;2840
;CCCCCCCCCCCCCCCC(=O)C1=C(O)C(CO)OC1=O;3-hexadecanoyl-4-hydroxy-5-(hydroxymethyl)-2,5-dihydrofuran-2-one;RK-682;368,5;6-C09;6;ICCB Known Bioactives Library;154639-24-4;PR112;10mM;Inhibitors:  VHR phosphatase inhibitor;DMSO;2840
;CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1;(2R)-2-{[6-(benzylamino)-9-(propan-2-yl)-9H-purin-2-yl]amino}butan-1-ol;Roscovitine;354,4;6-C10;6;ICCB Known Bioactives Library;186692-46-6;CC205;5mg/mL;Kinase inhibitors:  CDK inhibitor;DMSO;2840
;CC(=O)C1=C(O)C(C)=C(O)C(CC2=C(O)C3=C(OC(C)(C)C=C3)C(C(=O)\C=C\C3=CC=CC=C3)=C2O)=C1O;(2E)-1-{6-[(3-acetyl-2,4,6-trihydroxy-5-methylphenyl)methyl]-5,7-dihydroxy-2,2-dimethyl-2H-chromen-8-yl}-3-phenylprop-2-en-1-one;Rottlerin;516,5;6-C11;6;ICCB Known Bioactives Library;82-08-6;350-075;5mg/mL;Kinase inhibitors:  PKC delta inhibitor;DMSO;2840
;CC(=O)OCOC(C1=CC(=CC=C1OC1=CC=C(Br)C=C1)[N+]([O-])=O)P(=O)(OCOC(C)=O)OCOC(C)=O;({[(acetyloxy)methoxy]({[(acetyloxy)methoxy][2-(4-bromophenoxy)-5-nitrophenyl]methyl})phosphoryl}oxy)methyl acetate;RWJ-60475-(AM)3;620,3;6-D02;6;ICCB Known Bioactives Library;1069116-45-5;PR110;5mg/mL;Inhibitors:  CD45 phosphatase inhibitor;DMSO;2840
;CS(=O)C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC=NC=C1)C1=CC=C(F)C=C1;4-[4-(4-fluorophenyl)-2-(4-methanesulfinylphenyl)-1H-imidazol-5-yl]pyridine;SB 203580;377,4;6-D03;6;ICCB Known Bioactives Library;152121-47-6;EI286;5mg/mL;Kinase inhibitors:  Suppressor of MAPKAP kinase-2;DMSO;2840
;OC1=CC=C(C=C1)C1=NC(=C(N1)C1=CC=NC=C1)C1=CC=C(F)C=C1;4-[4-(4-fluorophenyl)-5-(pyridin-4-yl)-1H-imidazol-2-yl]phenol;SB 202190;331,3;6-D04;6;ICCB Known Bioactives Library;152121-30-7;EI294;5mg/mL;Kinase inhibitors:  MAP kinase inhibitor;DMSO;2840
;O\N=C1\C(\NC2=C\1C=CC=C2)=C1\C(=O)NC2=C1C=CC=C2;3-[(3E)-3-(hydroxyimino)-2,3-dihydro-1H-indol-2-ylidene]-2,3-dihydro-1H-indol-2-one;Indirubin-3'-monoxime;277,3;6-D05;6;ICCB Known Bioactives Library;160807-49-8;CC207;5mg/mL;Kinase inhibitors:  GSK-3beta inhibitor;DMSO;2840
;O=C1NC2=C(C=CC=C2)\C1=C1\NC2=C(C=CC=C2)C1=O;2-(2-oxo-2,3-dihydro-1H-indol-3-ylidene)-2,3-dihydro-1H-indol-3-one;Indirubin;262,3;6-D06;6;ICCB Known Bioactives Library;479-41-4;CC206;5mg/mL;Kinase inhibitors:  GSK-3beta inhibitor;DMSO;2840
;NCCC1=CNC2=C1C=C(O)C=C2;3-(2-aminoethyl)-1H-indol-5-ol;Serotonin;176,2;6-D07;6;ICCB Known Bioactives Library;153-98-0;NS820;5mg/mL;CNS receptor ligands:  serotonin receptor agonist;DMSO;2840
;OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1;5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol;Resveratrol;228,2;6-D08;6;ICCB Known Bioactives Library;501-36-0;FR104;5mg/mL;Activators:  SIRT1 activator;DMSO;2840
;O=C1CCC2=C(O1)C=CC1=CC=CC=C21;1H,2H,3H-naphtho[2,1-b]pyran-3-one;Splitomycin;198,2;6-D09;6;ICCB Known Bioactives Library;5690-03-9;GR331;10mM;Inhibitors:  sir2p inhibitor;DMSO;2840
;CC(C)(C)N1N=C(C2=C1N=CN=C2N)C1=CC=C(Cl)C=C1;1-tert-butyl-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine;PP2;301,8;6-D10;6;ICCB Known Bioactives Library;172889-27-9;EI297;5mg/mL;Kinase inhibitors:  Src family tyrosine kinase inhibitor;DMSO;2840
;OC1=CC(\C=C\C2=CC=C(O)C(O)=C2)=CC(O)=C1;5-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]benzene-1,3-diol;Piceatannol;244,2;6-D11;6;ICCB Known Bioactives Library;10083-24-6;EI271;10mM;Kinase inhibitors:  Syk inhibitor;DMSO;2840
;NC1=C2N=CN(C3CCCO3)C2=NC=N1;9-(oxolan-2-yl)-9H-purin-6-amine;SQ22536;205,2;6-E02;6;ICCB Known Bioactives Library;17318-31-9;CN140;5mg/mL;Inhibitors:  adenylate cyclase inhibitor;DMSO;2840
;OC(=O)CN1C(=O)C2=CC=CC3=CC=CC(C1=O)=C23;2-{2,4-dioxo-3-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaen-3-yl}acetic acid;Alrestatin;255,2;6-E03;6;ICCB Known Bioactives Library;51411-04-2;T112;5mg/mL;Inhibitors:  aldose reductase inhibitor;DMSO;2840
;[H][C@]12C[C@@H](NC)[C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=C(C=CC=C5)N2C4=C13;(2S,3R,4R,6R)-6-hydrogenio-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14,19,21,23,25,27-nonaen-16-one;staurosporine;466,5;6-E04;6;ICCB Known Bioactives Library;62996-74-1;EI156;5mg/mL;Kinase inhibitors:  kinase inhibitor - non-selective;DMSO;2840
;[H][C@@]12[C@H](O)[C@H](O)CN1CCC[C@H]2O;(1S,2R,8R,8aR)-octahydroindolizine-1,2,8-triol;swainsonine;173,2;6-E05;6;ICCB Known Bioactives Library;72741-87-8;S112;5mg/mL;Inhibitors:  protein glycosylation inhibitor;DMSO;2840
;CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1;(2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}ethyl)dimethylamine;Tamoxifen;371,5;6-E06;6;ICCB Known Bioactives Library;54965-24-1;S650;5mg/mL;Nuclear receptor ligands:  estrogen antagonist;DMSO;2840
;CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]1(C)C2[C@H](OC(=O)C2=CC=CC=C2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C3=CC=CC=C3)C3=CC=CC=C3)C(C)=C([C@@H](OC(O)=O)C1=O)C2(C)C;(1S,2S,4S,7R,9S,10S,12R,15S)-4-(acetyloxy)-12-(carboxyoxy)-1,9-dihydroxy-15-{[(2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl]oxy}-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0³,¹⁰.0⁴,⁷]heptadec-13-en-2-yl benzoate;Taxol = Paclitaxel;855,9;6-E07;6;ICCB Known Bioactives Library;33069-62-6;T104;5mg/mL;Inhibitors:  microtubule stabilizer;DMSO;2840
;ClC1=CC(\C=C(/C#N)C2=CN=CC=C2)=CC(Cl)=C1;(2Z)-3-(3,5-dichlorophenyl)-2-(pyridin-3-yl)prop-2-enenitrile;RG-14620;275,1;6-E08;6;ICCB Known Bioactives Library;136831-49-7;EI253;5mg/mL;Kinase inhibitors:  EGF-R tyrosine kinase inhibitor;DMSO;2840
;O=C1N(C2CCC(=O)NC2=O)C(=O)C2=CC=CC=C12;2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione;Thalidomide;258,2;6-E09;6;ICCB Known Bioactives Library;50-35-1;T115;5mg/mL;Inhibitors:  TNFalpha synthesis inhibitor;DMSO;2840
;;;Blank;;6-E10;6;ICCB Known Bioactives Library;;;;;;2840
;CN(C)CCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2;3-{1-[3-(dimethylamino)propyl]-1H-indol-3-yl}-4-(1H-indol-3-yl)-2,5-dihydro-1H-pyrrole-2,5-dione;GF-109203X;412,5;6-E11;6;ICCB Known Bioactives Library;133052-90-1;EI246;5mg/mL;Kinase inhibitors:  PKC inhibitor;DMSO;2840
;COC1=CC(\C=C(/C#N)C(N)=O)=CC(CSC2=NC3=CC=CC=C3S2)=C1O;(2E)-3-{3-[(1,3-benzothiazol-2-ylsulfanyl)methyl]-4-hydroxy-5-methoxyphenyl}-2-cyanoprop-2-enamide;Tyrphostin AG-825;397,5;6-F02;6;ICCB Known Bioactives Library;149092-50-2;EI267;5mg/mL;Kinase inhibitors:  HER-1,2 tyrosine kinase inhibitor;DMSO;2840
;COC1=CC(=O)OC(C1)\C=C\C1=CC=CC=C1;4-methoxy-6-[(E)-2-phenylethenyl]-5,6-dihydro-2H-pyran-2-one;Kavain (+/-);230,3;6-F03;6;ICCB Known Bioactives Library;500-64-1;NA136;5mg/mL;Ion channel ligands:  voltage-dependent Na channel inhibitor;DMSO;2840
;C(CN(CC1=CC=CC=N1)CC1=NC=CC=C1)N(CC1=CC=CC=N1)CC1=NC=CC=C1;{2-[bis(pyridin-2-ylmethyl)amino]ethyl}bis(pyridin-2-ylmethyl)amine;TPEN;424,5;6-F04;6;ICCB Known Bioactives Library;16858-02-9;AP300;5mg/mL;Inhibitors:  cell permable heavy metal chelator;DMSO;2840
;C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)C1=CC=C(C=C1)N(C)C;(2E,4E,6R)-7-[4-(dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dienamide;Trichostatin-A;302,4;6-F05;6;ICCB Known Bioactives Library;58880-19-6;GR309;5mg/mL;Inhibitors:  histone deacetylase inhibitor;DMSO;2840
;Cl.Cl.CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1;10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)-10H-phenothiazine dihydrochloride;Trifluoperazine;480,4;6-F06;6;ICCB Known Bioactives Library;440-17-5;CA310;5mg/mL;Inhibitors:  calmodulin inhibitor-possibly only at high concentrations!;DMSO;2840
;[H]C(O)(CC1OC(OC2OC(CO)C(O)C(O)C2NC(C)=O)C(NC(=O)\C=C/CC(C)C)C(O)C1O)C1OC([H])(N2C=CC(=O)NC2=O)C([H])(O)C1([H])O;(2Z)-N-(6-{2-[5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl}-2-{[3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,5-dihydroxyoxan-3-yl)-5-methylhex-2-enamide;Tunicamycin;718,7;6-F07;6;ICCB Known Bioactives Library;11089-65-9;CC104;5mg/mL;Inhibitors:  glycosylation inhibitor;DMSO;2840
;CS(O)(=O)=O.NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC2=CC=C(C=C2C=C1)C(N)=N;methanesulfonic acid 6-carbamimidoylnaphthalen-2-yl 4-carbamimidamidobenzoate;Nafamostat mesylate ;443,5;6-F08;6;ICCB Known Bioactives Library;82956-11-4;PI143;5mg/mL;Inhibitors:  Serine protease inhibitor;DMSO;2840
;OC1=CC(C=C(C#N)C#N)=CC=C1[N+]([O-])=O;2-[(3-hydroxy-4-nitrophenyl)methylidene]propanedinitrile;Tyrphostin AG-126;215,2;6-F09;6;ICCB Known Bioactives Library;118409-62-4;EI263;5mg/mL;Kinase inhibitors:  tyrosine kinase inhibitor;DMSO;2840
;COC1=CC=C(C=C(C#N)C#N)C=C1;2-[(4-methoxyphenyl)methylidene]propanedinitrile;Tyrphostin 1;184,2;6-F10;6;ICCB Known Bioactives Library;2826-26-8;EI190;5mg/mL;Inhibitors:  Calcineurin inhibitor;DMSO;2840
;CC(C)(C)C1=CC(C=C(C#N)C#N)=CC(=C1O)C(C)(C)C;2-[(3,5-di-tert-butyl-4-hydroxyphenyl)methylidene]propanedinitrile;Tyrphostin 9;282,4;6-F11;6;ICCB Known Bioactives Library;10537-47-0;EI215;10mM;Kinase inhibitors:  PDGF-R tyrosine kinase inhibitor;DMSO;2840
;[H][C@@]12CC[C@H](NCCCCCCN3C(=O)C=CC3=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC)C=C3;1-(6-{[(1S,10R,11S,14S,15S)-5-methoxy-15-methyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-2(7),3,5-trien-14-yl]amino}hexyl)-2,5-dihydro-1H-pyrrole-2,5-dione;U73122;464,6;6-G02;6;ICCB Known Bioactives Library;112648-68-7;ST391;5mg/mL;Lipid biosynthesis:  PLC inhibitor;DMSO;2840
;N\C(SC1=C(N)C=CC=C1)=C(\C#N)/C(/C#N)=C(\N)SC1=C(N)C=CC=C1;(2Z,3Z)-bis({amino[(2-aminophenyl)sulfanyl]methylidene})butanedinitrile;U-0126;380,5;6-G03;6;ICCB Known Bioactives Library;109522-58-2;EI282;5mg/mL;Kinase inhibitors:  MEK inhibitor;DMSO;2840
;CC(C)C1NC(=O)C(C)OC(=O)C(NC(=O)C(OC(=O)C(NC(=O)C(C)OC(=O)C(NC(=O)C(OC(=O)C(NC(=O)C(C)OC(=O)C(NC(=O)C(OC1=O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C;6,18,30-trimethyl-3,9,12,15,21,24,27,33,36-nonakis(propan-2-yl)-1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane-2,5,8,11,14,17,20,23,26,29,32,35-dodecone;Valinomycin;1111,3;6-G04;6;ICCB Known Bioactives Library;2001-95-8;KC140;5mg/mL;Ion channel ligands:  K+ ionophore;DMSO;2840
;OS(O)(=O)=O.[H][C@@]12N3CC[C@@]11C4=C(C=C(OC)C(=C4)[C@]4(C[C@@]5([H])CN(C[C@](O)(CC)C5)CCC5=C4NC4=C5C=CC=C4)C(=O)OC)N(C)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC;sulfuric acid methyl (1R,9R,10S,11R,12R,19R)-11-(acetyloxy)-12-ethyl-4-[(13S,15R,17S)-17-ethyl-15-hydrogenio-17-hydroxy-13-(methoxycarbonyl)-1,11-diazatetracyclo[13.3.1.0⁴,¹².0⁵,¹⁰]nonadeca-4(12),5(10),6,8-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2(7),3,5,13-tetraene-10-carboxylate;Vinblastine;909,1;6-G05;6;ICCB Known Bioactives Library;143-67-9;T116;10mM;Inhibitors:  tubulin inhibitor;DMSO;2840
;Cl.NCCCCCCNS(=O)(=O)C1=C2C=CC=C(Cl)C2=CC=C1;N-(6-aminohexyl)-5-chloronaphthalene-1-sulfonamide hydrochloride;W7;377,3;6-G06;6;ICCB Known Bioactives Library;61714-27-0;CA320;5mg/mL;Inhibitors:  calmodulin antagonist;DMSO;2840
;[H][C@@]12CCC(=O)[C@@]1(C)C[C@@H](OC(C)=O)C1=C2C(=O)C2=C3C(=CO2)C(=O)O[C@H](COC)[C@]13C;(1R,3R,5S,9R,18S)-18-(methoxymethyl)-1,5-dimethyl-6,11,16-trioxo-13,17-dioxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadeca-2(10),12(19),14-trien-3-yl acetate;Wortmannin;428,4;6-G07;6;ICCB Known Bioactives Library;19545-26-7;ST415;10mM;Lipid biosynthesis:  PI-3Kinase, other kinases inhibitor;DMSO;2840
;[H][C@@]1(CC[C@@H](CC1)C(=O)NC1=CC=NC=C1)[C@@H](C)N;(1R,4r)-4-[(1R)-1-aminoethyl]-N-(pyridin-4-yl)cyclohexane-1-carboxamide;Y-27632;247,3;6-G08;6;ICCB Known Bioactives Library;146986-50-7;EI299;10mM;Kinase inhibitors:  ROCK inhibitor;DMSO;2840
;Cl.[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2;methyl (1S,15R,18S,19R,20S)-18-hydroxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate hydrochloride;Yohimbine;390,9;6-G09;6;ICCB Known Bioactives Library;146-48-5;AC161;5mg/mL;CNS receptor ligands:  Adrenoreceptor antagonist (alpha);DMSO;2840
;CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1)\C=C\S(C)(=O)=O;benzyl N-[(1S)-1-{[(1S)-1-{[(1E,3S)-1-methanesulfonyl-5-methylhex-1-en-3-yl]carbamoyl}-3-methylbutyl]carbamoyl}-3-methylbutyl]carbamate;Z-Leu3-VS;551,7;6-G10;6;ICCB Known Bioactives Library;;ZW9170;5mg/mL;Protease inhibitors:  Proteasome inhibitor;DMSO;2840
;CN(C)C1=CC=CC(=C1)C(=O)NC1=CC(NC(=O)C2=CC=C(O)C=C2)=C(C)C=C1;N-{5-[3-(dimethylamino)benzamido]-2-methylphenyl}-4-hydroxybenzamide;ZM336372;389,4;6-G11;6;ICCB Known Bioactives Library;208260-29-1;EI298;10mM;Kinase inhibitors:  Raf inhibitor;DMSO;2840
;COC(=O)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)OCC1=CC=CC=C1)C(C)C)C(=O)CF;methyl (3S)-3-[(2S)-2-[(2S)-2-{[(benzyloxy)carbonyl]amino}-3-methylbutanamido]propanamido]-5-fluoro-4-oxopentanoate;Z-VAD(OMe)-FMK;467,5;6-H02;6;ICCB Known Bioactives Library;187389-52-2;P416;5mg/mL;Protease inhibitors:  Caspase inhibitor (broad spectrum);DMSO;2840
;CS(=O)(=O)NC1=C(OC2CCCCC2)C=C(C=C1)[N+]([O-])=O;N-[2-(cyclohexyloxy)-4-nitrophenyl]methanesulfonamide;NS-398;314,4;6-H03;6;ICCB Known Bioactives Library;123653-11-2;EI261;5mg/mL;Lipid biosynthesis:  Cox-2 inhibitor;DMSO;2840
;CC1=C(C)C(=O)C(CCCCC#CCCCC#CCO)=C(C)C1=O;2-(12-hydroxydodeca-5,10-diyn-1-yl)-3,5,6-trimethylcyclohexa-2,5-diene-1,4-dione;AA-861;326,4;6-H04;6;ICCB Known Bioactives Library;80809-81-0;EI216;5mg/mL;Lipid biosynthesis:  5-lipoxygenase inhibitor;DMSO;2840
;COC1=C(C\C=C(/C)CCC(O)=O)C(O)=C2C(=O)OCC2=C1C;(4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoic acid;Mycophenolic acid;320,3;6-H05;6;ICCB Known Bioactives Library;24280-93-1;A249;5mg/mL;Inhibitors:  Inosine-5'-monophosphate dehydrogenase inhibitor;DMSO;2840
;CC(C)=CC[C@@H](O)C1=CC(=O)C2=C(O)C=CC(O)=C2C1=O;5,8-dihydroxy-2-[(1R)-1-hydroxy-4-methylpent-3-en-1-yl]-1,4-dihydronaphthalene-1,4-dione;Shikonin;288,3;6-H06;6;ICCB Known Bioactives Library;517-89-5;CT115;10mM;Inhibitors:  Apoptosis inducer, p53 dependent;DMSO;2840
;[H][N+]1([H])CCO[B-]1(C1=CC=CC=C1)C1=CC=CC=C1;2,2-diphenyl-1,3,2-oxazaborolidin-3-ium-2-uide;2-APB;225,1;6-H07;6;ICCB Known Bioactives Library;524-95-8;AC1557;5mg/ml;Inhibitors:  IP3 receptor blocker;DMSO;2840
;OC1=CC=C(\C=C(\C#N)C(=O)OC\C=C\C2=CC=CC=C2)C=C1O;(2E)-3-phenylprop-2-en-1-yl (2Z)-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enoate;CDC;321,3;6-H08;6;ICCB Known Bioactives Library;132465-11-3;EI211;10mM;Lipid biosynthesis:  12-Lipoxygenase inhibitor;DMSO;2840
;[H][C@]1(O[C@]1([H])C(=O)CC\C=C\C\C=C\C)C(N)=O;(2R,3S)-3-[(4E,7E)-nona-4,7-dienoyl]oxirane-2-carboxamide;Cerulenin;223,3;6-H09;6;ICCB Known Bioactives Library;17397-89-6;G237;5mg/mL;Lipid biosynthesis:  Fatty acid biosynthesis inhibitor;DMSO;2840
;CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1;benzyl(2-chloroethyl)(1-phenoxypropan-2-yl)amine;Phenoxybenzamine;303,8;6-H10;6;ICCB Known Bioactives Library;63-92-3;CA305;5mg/mL;Inhibitors:  Calmodulin antagonist;DMSO;2840
;CN(C)CC(O)CN1C2=CC=C(Br)C=C2C2=C1C=CC(Br)=C2;1-(3,6-dibromo-9H-carbazol-9-yl)-3-(dimethylamino)propan-2-ol;Wiskostatin;426,1;6-H11;6;ICCB Known Bioactives Library;253449-04-6;T126;5mg/mL;Inhibitors:  N-WASP inhibitor;DMSO;2840
